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Stellingen 
1. Stress kan de pre-ovulatoire LH-piek verstoren. 
(dit proefschrift) 
2. Er is relatief weinig LH nodig om Graafse follikels te laten ovuleren. 
(dit proefschrift) 
3. Onder stress-omstandigheden is de pre-ovulatoire LH-piek afhankelijk van 
Vasopressine. 
(dit proefschrift) 
4. CRH, endogene Opioiden en GABA spelen geen belangrijke rol bij de invloed 
van stress op de pre-ovulatoire LH-piek. 
(dit proefschrift) 
5. Substitutie van oestradiol en progesteron na ovariëctomie maakt van een 
rat nog geen goed model voor onderzoek naar de invloed van stress op de 
pre-ovulatoire LH-piek. 
(Salisbury et al. (1980), Endocrinology 101:1194-1202) 
(Kubo et al. (1983), Endocrinol. Jpn. 30:419-433) 
6. Het ontstaan van "luteinized unruptured follicles" kan niet verklaard worden 
als veroorzaakt door een te lage LH-afgifte alleen. 
(Mattheij & Swarts (1995), Eur. J. Endocrinol. 132:91-96) 
7. Alleen een grote bedreiging van hun welzijn zal dieren ervan weerhouden 
om zich voort te planten. 
(Moberg G.P. (1985). In: Animal stress, The Williams & Wilkins Company, 
Baltimore, biz 245) 
8. Bij het induceren van ovulatie in de vrouwelijke meerval zijn feromonen 
betrokken. 
(proefschrift J.W. Resink (1988), Utrecht) 
9. Mannelijke watervlooien onstaan pas als het voor vrouwelijke moeilijk wordt 
om te overleven. 
10. De voorgeschiedenis van het proefdier is van invloed op de uitkomsten van 
de dierproef. 
1 1 . Hersenen zijn gecompliceerder als je denkt. 
12. Omdat "verwacht rendement" en "risico" subjectieve begrippen zijn, zullen 
de beurskoersen altijd beïnvloed worden door sentimenten. 
13. Een geaccepteerde hypothese blijft een hypothese en laat dus vele vragen 
onbeantwoord. 
14. Wachtgeld betekent soms "wacht op je geld". 
1 5. De besluitvorming in de Tweede Kamer wordt versluierd door het gebruik 
van voor leken onduidelijke afkortingen. 
16. Hoewel het geslacht van een ongeboren baby doorgaans niet bekend is 
wordt ze in het spraakgebruik altijd aangeduid als "h i j " . 
Marjolijn M. Roozendaal 
Stress and the hypothalamus-pituitary-gonadal axis in the cyclic rat 
Wageningen, 20 november 1997 
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Chapter 1 
General introduction 
1 Introduction 
The concept of homeostasis was first formulated by Bernard (1). He recog-
nized the interaction between the external environment ("milieu extérieur") that 
surrounds the organism and its internal environment ("milieu intérieur"). An 
organism is constantly subjected to changes in the external environment. By 
maintaining the internal environment within fixed limits, organisms have evolved 
to become more independent from changes in the outer world. This maintenance 
of a relative stability of the internal environment was termed homeostasis by 
Cannon (2). Fluctuations in the internal environment are tolerated but are kept 
within limits. When external influences alter a physiological variable (e.g. tem-
perature, blood pressure) so that a deviation from a physiological setpoint is 
detected, feedback mechanisms will be activated, that re-adjust the variable 
towards the physiological setpoint. Activation of feedback systems in order to 
reinstate homeostasis is termed "adaptation". 
In a constantly changing external environment, maintenance of a relative 
stability of the internal environment (homeostasis) is necessary for an organism 
to survive. An environmental condition or factor that threatens or disturbs 
homeostasis is usually referred to as a stressor. Activation of behavioural, auto-
nomic and endocrine mechanisms, the stress response, aims at protecting the 
organism against (potential) damaging conditions. 
2 Stress 
Stress is an ubiquitous feature of life and the concept of stress has been 
widely and frequently discussed. After many decades of stress research, an 
exact definition of the phenomenon stress is still not established. For an animal 
to survive, it must maintain its vital variables within preset limits. Thus, specific, 
routinely operating homeostatic mechanisms, consisting of behavioural and 
physiological programmes, control the vital functions and protect homeostasis. 
Any condition that could lead to a change in such functions beyond the capacity 
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of these mechanisms - and thus threatens homeostatic control - triggers a 
general defence mechanism, the stress response, that includes behavioral, 
autonomic and neuroendocrine adaptations aiming at removal of the threat and 
reestablishment of homeostasis. Whether or not a stimulus represents a signific-
ant threat to control (and is a stressor), is assessed in the central nervous sys-
tem (CNS). This not only depends on qualities of the stimulus condition itself 
(e.g. intensity, frequency, duration), but also on characteristics of the animal 
such as genetic constitution (e.g. species, selection line, gender), pre- and 
postnatal development, prior experiences and skills (e.g. history of the indi-
vidual, learning, memory), and the physiological (normal or pathological) and 
psychological state of the animal at that particular moment (Fig. 1). 
Stimulus 
CNS 
Perception of 
stressor 
Organization of 
biological defence 
Biological response 
behavioural 
autonomic 
neuroendocrine 
V 
- experience 
- genetic constitution 
- physiological state 
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STRESS 
"RESPONSE 
Change in 
biological function 
/\ 
Fig. 1. Schematic representation of the response to a potential stressful event and ex-
amples of factors that influence this response (adapted from Moberg [3D 
The stress response comes in several modes. Active behaviour can be used to 
approach and fight or to flee from the stressor (fight-flight response). When an 
active response is not possible or available, behavioural inactivity is displayed. 
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Each mode is parallelled by a different set of physiological reactions, that basic-
ally thought to concern mobilization and redistribution of energy to allow or 
prepare for the behavioural response to be generated (4). Thus, energy is mobil-
ized from stores, and storage of energy is blocked. Anabolic processes are 
deferred, and physiological functions which normally cost energy and are not 
needed to survive the stressful situation, are suppressed (such as digestion, 
growth and repair, immunity, and reproduction). Thus, the stress response 
comes with costs for the organism, and during prolonged stress it can therefore 
become as damaging as the stressor itself. If the stress experience lasts too long 
or the stress response can not be appropriately terminated at the end of stress, 
stress-related disturbances or diseases can emerge. These disturbances actually 
concern physiological systems that are affected during the stress response. It is 
generally thought, that they arise as a consequence of biochemical/cellular 
changes induced by mediators of the stress response (hormones, neuropeptides, 
neurotransmitters). 
The neuroendocrine response to stress has been the subject of extensive 
research. A major focus of these studies has been on the hypothalamus-pitu-
itary-adrenal (HPA) axis. With the onset of stress, corticotropin-releasing hor-
mone (CRH) is secreted from the hypothalamus into the hypophysial portal 
circulation (see review 5). CRH then triggers the release of adrenocorticotropic 
hormone (ACTH) from the pituitary, which in turn triggers the release of 
glucocorticoids from the adrenal cortex (6-9). Activation of the HPA axis blocks 
energy storage, helps in mobilizing energy from storage sites, and inhibits 
anabolic processes such as growth, immunity and reproduction. Therefore, a 
relationship is suggested between hormones of the HPA axis (which are released 
during stress) and those of the hypothalamic-pituitary-gonadal (HPG) axis (which 
are also influenced by stress). 
3 The reproductive cycle of the female rat 
3.1 Ovarian follicular cycle 
In the adult laboratory rat, the ovarian cycle continues throughout the year 
and has a length of 4 or 5 days. The stages of the oestrous cycle in the rat can 
be determined by microscopical rating of the cell types that appear in the vaginal 
smear (see review 10). Pro-oestrus is characterized by a predominance of 
nucleated epithelial cells. On oestrus, the dominant cell is the nonnucleated, 
cornified squamous epithelial cell. During metoestrus, leucocytes appear along 
with a significant number of cornified squamous epithelial cells. The stage of 
dioestrus is characterized by a predominance of small leucocytes interspersed by 
a few nucleated epithelial or cornified squamous epithelial cells. 
At birth the ovaries contain approximately 35000 oocytes. The oocytes have 
entered into the prophase of meiosis I which is progressed to the dictyate or 
"resting stage" 4 days after birth (11). Only a small fraction of these viable 
oocytes will develop into mature ova. The oocyte is surrounded by a single layer 
of flattened epithelium-derived granulosa cells; the combined structure is called 
a primordial follicle. After transformation of the follicular epithelial cells into a 
single layer of cuboidal cells, the composite structure is referred to as a primary 
follicle. During each oestrous cycle a random group of primary follicles develops 
into secondary follicles; a fully developed mature follicle is known as a graafian 
follicle. After rupture of the mature follicle and liberation of the ovum during 
ovulation, the cells of the follicle are luteinized which leads to formation of the 
corpus luteum. 
3.2 Hormonal regulation of the ovarian cycle (see reviews 10,12) 
Luteinizing hormone and follicle stimulating hormone 
The ovaries perform two basic functions: production and release of gametes 
and production and secretion of steroids. Both functions are under control of 
gonadotropic hormones i.e. luteinizing hormone (LH) and follicle stimulating hor-
mone (FSH). Hypothalamic release of the gonadotropin releasing hormone 
(GnRH) induces the secretion of these gonadotropins from the anterior pituitary 
into the systemic circulation. The secretion of LH and FSH during the ovarian 
cycle of the rat is maintained at low levels on metoestrus, dioestrus, and the 
morning of pro-oestrus (Fig. 2). This basal gonadotropin secretion is regulated by 
gonadal steroids (oestrogen, progesterone and testosterone) through negative 
feedback action on hypothalamus and pituitary levels. On pro-oestrus this negat-
ive feedback action converts into a positive feedback by rising concentrations of 
circulating oestrogens, which are secreted by ripening follicles, and subsequently 
a surge of LH and FSH is induced (Fig. 2). The LH surge induces resumption of 
meiosis of the oocyte, triggers ovulation on the ensuing morning, and induces 
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transformation of the ovulated follicle into a corpus luteum (luteinization). Pre-
cocious follicle luteinization can lead to luteinized unruptured follicles (LUF). 
Mattheij et al. (14,15) showed that an injection of a small amount of LH in the 
morning of pro-oestrus causes LUF. The FSH surge is of influence upon the de-
velopment of graafian follicles of the following oestrous cycle. 
It has been known for many years that the preovulatory rise of oestrogen 
together with a daily signal generated by the biological clock are the primary 
determinants of GnRH secretion and the subsequent LH and FSH surge (16). It 
has been clearly established that the preovulatory surge of LH and FSH in intact 
rats occurs at a fixed time relative to the light-dark cycle. The onset of the pro-
oestrous LH and FSH surge can be predicted from the known light-dark schedule 
i.e. approximately half of the light period plus two hours. 
OESTRUS METOESTRUS DIOESTRUS PRO-OESTRUS OESTRUS 
Fig. 2. Schematic diagram of the hormone profiles of LH (—), FSH ( ), oestradiol 
( — . — ) and progesterone ( — — ) during the oestrous cycle of the rat. Black bar represents 
the dark period of the lighting cycle, (adapted from Smith et al. [13]) 
Gonadotropin-releasing hormone 
GnRH provides a humoral link between the brain and the reproductive system. 
GnRH neurons in the rat are located in the diagonal band of Broca (DBB), the 
medial nucleus of the septum, the medial preoptic area (MPOA), and the anterior 
hypothalamic area (AHA), and also in the retrochiasmatic area of the medial 
hypothalamus (see reviews 10,17). In the rat, tracer studies showed that vir-
tually (>90%) all GnRH neurons project to the median eminence (ME) irrespec-
tive of sex, age or gonadal status of the animal (18). The GnRH neurons that 
project to the ME are concentrated basally in the midline regions from the MPOA 
rostrally and through the retrochiasmatic area caudally. GnRH is released in a 
pulsatile manner from the ME into the portal system and then transported to the 
anterior pituitary, where it stimulates release of LH and FSH. 
GnRH neurons are regulated by oestrogens (and progesterone) but because 
these GnRH neurons do not have oestrogen receptors (19), it is believed that 
they are controlled by interneurons containing oestrogen receptors. At pro-oes-
trus there is a shift from a negative to a positive feedback action of oestrogen 
on the HPG axis (see reviews 10,12,20). A steady rise of oestrogens on pro-
oestrus entrains the biological clock with neurosecretory events in peptidergic 
systems that participate in the induction of the LH and FSH surge. This positive 
feedback action of oestrogens requires the synergistic participation of progester-
one (21). Increments of progesterone facilitate the neural event leading to 
hypersecretion of GnRH from the ME nerve terminals. Additionally, the increased 
levels of progesterone also prevent the recurrence of a LH and FSH surge the 
following day. 
It was suggested that on pro-oestrus the biological clock operates in two 
stages to induce two distinct neurosecretory events (22). Initially, the clock 
disrupts the inhibitory influence of hypothalamic signals (including opioids) on 
the morning of pro-oestrus. A gradual restraint on the hypothalamic inhibitory 
systems may stimulate an increase in the rate of posttranslational processing 
leading to accumulation of GnRH in ME nerve terminals. The evidence that 
prevention of this disinhibition interrupted the accumulation of GnRH in the 
medial basal hypothalamus (MBH) is in accord with this suggestion (23). 
Subsequently, the clock may act again to augment neurochemical signalling for 
accelerated release of GnRH into the portal system. 
The peptidergic pathways that propagate and transmit impulses for the GnRH 
surge reside in the suprachiasmatic nucleus (SCN) - medial preoptic nucleus 
(MPN) - arcuate nucleus (ARC) - MPOA - ME neural complex. The timely initi-
ation of the impulses is entrained to the photoperiodic input reaching the SCN 
(biological clock). An increase in ME levels of GnRH is the most consistent 
earliest event, which occurs 1-2 h before the onset of the LH surge on pro-
oestrus (24). This is observed in adult cyclic (25-27) and prepubertal rats (28). 
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The occurrence of this ME GnRH response is closely tied to the onset of a rise in 
portal GnRH levels. After stimulation of the MPOA on pro-oestrus the GnRH 
content of the ME is decreased (29), and GnRH release into the portal system is 
increased compared to other days of the cycle (30). 
On pro-oestrus there is an increased pulsatile release of GnRH but also the 
anterior pituitary is sensitized to the actions of GnRH (31-33). The rapid increase 
in pituitary responsiveness to GnRH that occurs on pro-oestrus has been 
attributed to the acute self-priming action of GnRH, in combination with a posit-
ive effect of oestrogen at the level of the pituitary. Indeed, exposure of the pitu-
itary to GnRH sensitizes the pituitary to further injections of GnRH (34). The 
sensitivity is also augmented by direct actions of progesterone (35,36) and there 
is evidence that the neuromediators galanin (37), pituitary adenylate cyclase 
activating peptide (38) and neuropeptide Y (39,40) enhance the responsiveness 
of gonadotropes to stimulation of GnRH. There is no evidence that the GnRH 
pulse frequency is increased during the initiation of the LH surge but the 
increase in GnRH release appears to take the form of pulses of increased ampli-
tude (see review 41). Opioids may be involved in the increase of the amplitude 
of GnRH release that results from the positive feedback action of steroids (42). 
A major difficulty when studying the GnRH neuronal system is the distribution 
of GnRH neurons and the high number of factors (e.g. classical 
neurotransmitters, neuropeptides, steroids, etc.) that have been reported to 
modulate directly or indirectly GnRH neurons at the level of the cell bodies or at 
their axonal endings in the ME (Fig. 3). There is extensive literature on the 
potential role of various neuromediators (neurotransmitters and neuropeptides) in 
the regulation of LH release (see reviews 20,44). Neurotransmitters involved in 
the regulation of LH release are for instance norepinephrine, epinephrine, 
dopamine, serotonin, histamine, gamma aminobutyric acid, and glutamate. Also 
neuropeptides are involved in the regulation of LH secretion, i.e. neuropeptide Y, 
galanin, oxytocin, vasopressin, vasoactive intestinal polypeptide, CRH and 
endogenous opioids. The modulation of GnRH release depends on complex inter-
actions between several of these factors within a hypothalamic network. 
Depending on the steroid environment, these neuromediators may play facilitory 
or inhibitory roles in GnRH secretion. 
Fig. 3. Summary of factors which modulate directly or indirectly GnRH neuronal activity 
from either cell bodies or nerve terminals. Solid arrows, stimulatory effect; dashed 
arrows inhibitory effect. AVP, arginine vasopressin; BEND, ß-endorphin; CRH, 
corticotropin-releasing hormone; DA, dopamine; E, epinephrine; EOP, endogenous opioid 
peptides; GABA, gamma aminobutyric acid; GAL, galanin; 5-HT, serotonin; NE, 
norepinephrine; NPY, neuropeptide Y; OT, oxytocin; VIP, vasoactive intestinal peptide, 
(modified after Rivest and Rivier [43]) 
4 Stress and reproduction 
A well known consequence of stress is disruption of fertility. In animals, one 
of the earliest studies discussing the relationship between stress and reproduc-
tion, was based on the effects of overcrowding in both natural and captive 
animal populations (45). Undoubtedly reproduction in male and female is vulner-
able to the effects of stress. A primary mechanism by which stress can disrupt 
reproduction is by altering the control of gonadotropin secretion (Fig. 3). In most 
studies an inhibiting effect of stress on gonadotropin secretion has been found 
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(table 1) but shortly after application of a stressor a small transient rise of basal 
LH release can be induced (table 1a,b: 46-49). During the oestrous cycle of the 
female rat stressors appear to have their greatest impact just prior to ovulation, 
when precise neuroendocrine control is most essential for reproductive success. 
However, the exact mechanism through which stress alters reproductive func-
tion remains largely unknown. 
Many investigators have studied the effects of various stressors on LH and to 
a lesser extent FSH secretion in the rat (table 1a,b). Most of the studies have 
been performed with male rats or with ovariectomized or ovariectomized steroid-
primed female rats. Only a few studies have used intact cyclic female rats to 
investigated the influence of stress (table 1a: 50,51) on the surge of 
gonadotropins. The effect of administration of potential stress-related neuro-
mediators in the intact cyclic rat has been studied more detailed (table 2a,b). 
Stress can influence reproductive functions at the three levels of the HPG axis; 
at the hypothalamus to alter GnRH secretion, at the pituitary to interfere with 
GnRH-induced gonadotropin release, and at the gonads to alter the stimulatory 
effect of gonadotropins on steroid secretion. 
The pathways via which stress influences reproductive functions have been 
subject of intense research for many years. Investigation of this relationship is 
complicated by the variety of responses an animal can display under stress and 
the complex regulation of the processes of reproduction. Selye (52) was the first 
who suggested a possible relationship between hormones and neuropeptides of 
the HPA axis, which are liberated during stress, and those involved in the HPG 
axis. Apart from glucocorticoids, indeed, CRH, the opioid ß-endorphin (ßEND) 
and vasopressin (AVP) may play a role in the effect of stress on reproductive 
functions (table 3, and sections below). Additionally, administration of CRH, 
AVP and ßEND can inhibit the release of gonadotropins and ovulation (table 
2a,b). Besides these hormones and peptides, various other factors may be 
involved in stress-induced inhibition of reproductive functions. Among these, the 
major inhibitory neurotransmitter of the brain, gamma aminobutyric acid (GABA) 
is a likely candidate. GABA can alter the activity of the HPA and HPG axis; 
GABA metabolism and binding and function of its receptors are influenced by 
several stressors (see review 53 and table 3). 
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4.1 Corticotropin-releasing hormone 
In 1955, the first convincing demonstrations were provided of the existence 
of a factor derived from the hypothalamus that could elicit ACTH secretion from 
the pituitary (54, 55). This factor was named corticotropin-releasing factor (CRF) 
because of its ability to stimulate secretion of ACTH. In 1981, Vale et al. (7) 
succeeded in determining the amino acid sequence of ovine CRF and since then 
this factor is also indicated as corticotropin-releasing hormone (CRH). CRH is a 
41-amino acid hormone derived from a 196-amino acid precursor. The amino 
acid sequence of this hormone has been determined in sheep, man, rat, pig, 
goat and cattle; in all it shows a high homology in structure (56). In the 
hypothalamus, it is synthesized in parvocellular neurons of the paraventricular 
nucleus (PVN) where it is colocalized with a variety of peptides, e.g. oxytocin 
and vasopressin (8,57-60). Paraventricular neurons project to the ME, and to the 
pituitary. In addition to its hypothalamic localization, CRH-containing cell bodies 
and binding sites have been identified in many extra-hypothalamic sites including 
the neocortex, areas of the limbic system involved in emotion and stress re-
sponses, such as the amygdala, nucleus accumbens, and hippocampus and 
regions involved in the regulation of the autonomic nervous system (locus 
ceruleus, nucleus of the solitary tract, olfactory bulb, cerebral cortex and the 
spinal cord) (5,59-62). The wide distribution of CRH and its binding sites in the 
CNS has implicated the hormone in the regulation of endocrine, autonomic and 
behavioural processes. 
CRH is the major endogenous corticotropin releasing hormone, although a 
number of other factors (e.g. AVP, oxytocin (OXT) and endogenous opioids) 
participate in the regulation of ACTH release (62-64). ACTH subsequently elicits 
the secretion of glucocorticoids from the adrenal cortex which exert a negative 
feedback on hypothalamus and pituitary sites (66,67). Activation of the HPA 
axis is considered to be characteristic of the stress response and serves to 
counteract disturbances of homeostasis. 
In addition to its ability to activate the HPA axis, central CRH may function as 
neurotransmitter in the brain. Indeed, central administration of CRH has indic-
ated that the hormone has a variety of endocrine, physiological, neurochemical 
and behavioural activities that are not shared with ACTH and corticosterone. It 
has been recognized that a lot of the effects of CRH resembled those observed 
during stress, suggesting that CRH may be an endogenous mediator of such 
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responses (table 4). 
The observation that intracerebroventricular (icv) injection of CRH suppresses 
the activity of the HPG axis in castrated male, and in intact and ovariectomized 
female rats (table 2a: 69-72) indicates that CRH plays a role in stress-induced 
inhibition of reproduction. In the pro-oestrous intact female rat, central admin-
istration of CRH attenuates LH secretion by inhibiting GnRH release into the 
hypophysial portal system (70). During stress conditions, central administration 
of the CRH antagonist a-helical CRH prevented the inhibition of LH release 
induced by footshocks in castrated male rats (73). 
Table 4: Responses following CRH administration that resemble those observed during 
stress (adapted from Dunn and Berridge (67)) 
Endocrine 
Physiological 
Electrophysiological 
Neurochemical 
Behavioural 
decreases LH (GnRH) secretion 
decreases growth hormone (growth-releasing hormone) 
secretion 
initiates the hypothalamic-pituitary-adrenal response 
increases large bowel transit and fecal excretion 
decreases gastric acid secretion, decreases gastric 
emptying and small intestinal transit 
activates the EEG; seizures at higher doses 
increases the activity of cerebral noradrenergic 
and dopaminergic neurons 
decreases sexual behaviour in males and females 
increases grooming 
decreases feeding 
increases locomotor activity 
decreases responding in a conflict test 
decreases social interaction 
enhances footshock-induced freezing 
The origin of CRH neurons innervating GnRH neurons remains unclear (43). 
Also the mechanisms through which endogenous CRH can influence GnRH 
release are not fully understood. MacLusky et al. (74) demonstrated a direct 
anatomical connection between CRH axon terminals and dendrites of GnRH-
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secreting neurons. However, the mechanisms through which CRH influences 
GnRH release are likely to involve the activation of other pathways, such as 
those dependent on vasopressin and/or endogenous opioids (69,75-77). 
4.2 Vasopressin 
In 1953, Du Vigneaud et al. isolated two hormones from the pituitary, AVP 
(arginine vasopressin) and OXT (78,79). AVP and OXT are peptides made up of 
nine amino acids. The sequence of AVP differs in only two positions of OXT. 
These differences are sufficient to markedly alter the biological activities, alt-
hough AVP and OXT can act on each others' receptors due to chemical similar-
ity in structure. AVP is synthesized in the supraoptic nucleus (SON) and PVN. 
Two distinct populations of neurons supply AVP to the anterior pituitary: parvi-
cellular neurons from the PVN which terminate in the ME, and magnocellular 
neurons from the PVN and SON which terminate in the posterior pituitary (80). 
In addition, AVP is also distributed in extrahypothalamic structures (81-83). 
A well-known effect of AVP on the pituitary is the stimulation of ACTH re-
lease and the potentiation of CRH effects. AVP modulates the effect of CRH on 
ACTH secretion and appears to take part in mediating the ACTH response to 
stress (see review 84). However, little attention has been paid on a role of AVP 
in stress-induced alterations of the HPG axis. Several studies suggest that the 
release of CRH and AVP in the portal system is increased during stress (85-88) 
but only a few studies are focused on a possible role for AVP in control of LH 
secretion during stress. In ovariectomized (OVX) rats, basal LH tended to 
increase following ether stress. LH levels were significantly lower, however, in 
rats pretreated with an AVP-antiserum than in rats pretreated with normal rabbit 
serum (49). In AVP deficient male Brattleboro rats, histamine stress had no 
inhibiting effect on LH whereas in control parent strain rats (Long Evans) basal 
LH was suppressed (89). In the OVX rhesus monkey, vasopressin antagonism 
prevented hypoglycemia-induced LH suppression (90). In addition, administration 
of high doses of AVP caused suppression of the LH surge and ovulation in intact 
and OVX steroid-primed female rats (table 2a: 91-93). 
The actions of AVP, like those of CRH, are probably exerted at the level of 
the hypothalamus because AVP does not affect LH secretion from isolated pitu-
itary tissue in vitro (49). Anatomical studies indicate that CRH neurons, which 
also contain AVP (94), lie in close apposition with ß-endorphinergic neurons 
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within the hypothalamus (95). Moreover, AVP, like CRH (96,97), has been 
shown to stimulate the release of ßEND from hypothalamic tissue in vitro (98) 
and in vivo (76). Burns et al. (77) demonstrate that CRH acts via AVP to release 
ßEND from hypothalamic slices of male rats in vitro, and there is evidence that 
endogenous opioid peptides can mediate the CRH-induced inhibition of LH 
secretion (69, 70, 99, 100). 
4.3 Endogenous opioid peptides 
The first endogenous opioid peptides (EOP), the enkephalins, were isolated 
from brain tissue and sequenced in 1975 (101). At present three families of EOP 
are known. Each family is derived from a separate precursor: ßEND is derived 
from pro-opiomelanocortin (POMC), enkephalins are derived from proenkephalin 
and dynorphins are derived from prodynorphin. Peptides derived from POMC 
include the opioid ßEND and the non-opioid hormones ACTH and oc-melanocyte 
stimulating hormone (a-MSH). All three families of EOP have been identified in 
the brain, each with a characteristic distribution within particular neural 
networks (see reviews 20,44) . 
The multiple opioid effects are mediated by multiple opioid receptors. Opioid 
receptors have been subdivided into three "main" classes: p, ô and K receptors 
(102-104). Each of the three opioid peptide precursors generates predominantly 
ligands to one of the three opioid receptor types. Pro-enkephalin derived 
enkephalins bind preferentially to the 5-receptors, while pro-dynorphin derived 
opioids are all K-ligands, and POMC derived opioids bind to the //-receptors. This 
categorization was initially based on distinct behavioural syndromes correlated 
to different classes of opiate drugs. EOP and their receptors have also been 
localized in the hypothalamus suggesting that EOP may play a role in reproduct-
ive endocrinology. Research in this area during the last years has revealed many 
aspects of the role of EOP in regulation of reproduction which is reviewed by 
several authors, (see reviews 20,41,44). In summary, it has been demonstrated 
that EOP neurons tonically inhibit secretion of LH in the rat through intrahypo-
thalamic inhibition of GnRH release, except for a brief interval during the pro-
oestrous LH surge in the female or during the period of a progesterone-induced 
LH surge in the oestrogen-primed OVX rat. Using selective p opioid agonists and 
antagonists it was demonstrated that mainly the /y-receptor is involved in the 
inhibition of hypothalamic GnRH secretion. Administration of the opioid receptor 
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antagonist naloxone stimulates LH release and can reverse the exogenous opioid 
induced suppression of LH secretion (105-108). A prevailing theory holds that 
the tonic EOP inhibition of GnRH release may be important in transmission of the 
negative feedback of gonadal steroids. The activation of the EOP system is, at 
least partly, dependent on gonadal steroids. Opioid agonists usually inhibit, and 
opioid antagonists stimulate LH secretion, but they fail to evoke an LH response 
in long-term OVX rats; the response is restored after substitution with 
oestradiol, or with the combination of oestradiol and progesterone. The primary 
action of EOP in the rat appears to involve suppression of the amplitude of 
GnRH release while gonadal steroids decelerate the rate of pulse generation. 
Therefore, it seems that opioids may play an important role in GnRH release that 
results from the positive feedback of gonadal steroids (41,42). 
As GnRH neurons do not contain steroid receptors, the action of steroids 
must be mediated by other neurons. Opioids appear to modulate the regulation 
of GnRH directly (see reviews 41,44) at the hypothalamic level and/or by mul-
tiple interactions with other central regulatory mechanisms. Within the hypo-
thalamus, opioids can affect the action of dopamine, noradrenaline, adrenaline, 
serotonin, GABA, neuropeptide Y, CRH, excitatory amino acids, etc. 
Several studies have suggested a role for EOP in the effects of stress on re-
productive parameters. Experimental evidence exists that stress-related inhibition 
of LH secretion is mainly mediated by // opioid receptors. Pretreatment with 
naloxone or naltrexone (opioid receptor antagonists) which have a high affinity 
for ^-receptors, reverses inhibitory effects on LH by various stressors in mainly 
male rats and ovariectomized female rats (table 1a,b: 49,51,109-111). In the 
intact female rat, it was demonstrated that footshock stress alters reproductive 
function by inhibiting LH secretion through mediation of EOP (51). In addition, as 
mentioned above, opioids may be involved in the mediation of the inhibitory 
actions of stress-ipduced CRH and AVP release on GnRH secretion. 
4.4 Gamma aminobutyric acid 
GABA was discovered in the nervous system in 1950 (112). GABA is syn-
thesized in neural tissues through decarboxylation of L-glutamic acid. The reac-
tion is catalyzed by L-glutamic acid decarboxylase (GAD). GABA is degraded in 
the CNS by GABA-a-oxoglutarate transaminase (GABA-T). First evidence of the 
general inhibitory role of GABA was obtained from the observation that the 
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enzyme GAD was found in high concentration in inhibitory axons of the crayfish 
stretch receptor system, and not in excitatory axons (113). Later GABA was 
also localized in areas of the vertebrate nervous system with known inhibitory 
functions. From biochemical and electrophysiological studies, GABA has been 
shown to be widely distributed throughout the mammalian nervous system (see 
review 114). Neurochemical changes affecting the GABAergic system are 
judged by measurements of i.e. GABA concentrations, GABA turnover, or the 
activity of the enzyme GAD. 
There are at least two kinds of receptor classes, GABAA (chloride channel-
activating) and GABAB receptors (guanosine triphosphate coupled, also an auto-
receptor to control the release of GABA itself from nerve endings) (115,116). 
The primary effect of central GABAB receptor activation is a diminution in mem-
brane K+ and Ca + + conductance. The GABAA receptor is a complex entity; in 
addition to the GABA recognition site it consists several other binding sites: a 
benzodiazepine receptor, receptor sites for convulsant and anticonvulsant drugs 
such as Picrotoxin and barbiturates, and a receptor binding site for steroids (see 
reviews 53,115,116). Not all GABA receptor complexes contain all the compon-
ents of the receptor complex as described above. 
GABA appears to have a significant influence on pituitary hormone secretion, 
primarily through direct hypothalamic effects. It has been proposed that GABA 
neurons in the MPOA mediate the negative feedback action of oestrogen on 
GnRH (117,118). GAD-containing neurons were shown to have oestrogen 
receptors (118) and to synapse on GnRH-containing neurons (119). Additionally, 
GABA release in the preoptic hypothalamic region decreased coincident with the 
oestrogen-induced LH surge in OVX rats (117,120,121). Central administration 
of GABA in the intact female rat suppressed the LH surge and ovulation. Admin-
istration of the GABAA agonist muscimol or the GABAB agonist baclofen in the 
steroid-primed female rat caused also a suppression of the steroid-induced LH 
surge (table 2b: 122-126). 
GABA inhibits the activity of the HPA axis, and therefore influences the stress 
response (see review 53). Many studies have been done on the effect of a 
variety of stressors on GABAergic functions in several brain regions. For 
instance, in the hypothalamus of male rats, pain reduced GABA levels whereas 
5 min of restraint did not alter GABA levels. Three hours of immobilization stress 
or 30 sec/day of ether stress (during 20 days) induced increased hypothalamic 
GABA levels (table 3: 127-131). The effect of stress on the GABA content in 
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the hypothalamus seems to depend on the type of stressor applied and the 
stress protocol. Various stressors can also induce alterations in GABAA receptor 
binding and function, especially at the benzodiazepine binding site, which have 
been the subject of several studies (see review 53). However, little attention has 
been paid to the involvement of GABA as inhibitory neurotransmitter in the 
altered gonadotropin secretion during stress. In women with stress-related 
anovulation, treatment with alprozalam, a benzodiazepine, restored LH 
pulsatility, and increased mean LH pulse frequency and amplitude (132). In the 
latter, activation of the GABA receptor seemed to stimulate GnRH release by 
inhibition of the stress-induced CRH release. To our knowledge no studies have 
been done on the role of GABA as a mediator of the stress-induced inhibition of 
GnRH release in the female rat . 
5 Outline of this thesis 
Stress of physiological or emotional origin can influence the release of GnRH 
and subsequently that of LH and FSH. In the intact female rat, the LH surge on 
the day of pro-oestrus induces meiotic resumption of the oocyte, triggers ovula-
tion and induces luteinization of the follicle. An inadequate LH surge may induce 
premature luteinization in graafian follicles and/or subsequently prevent ovula-
tion. Very little research has been done with respect to the effect of stress on 
the pro-oestrous LH and FSH surge and subsequent effects on ovarian function 
in the intact female rat. It has been reported that footshock stress results in an 
inhibition of the pro-oestrous LH surge and ovulation (51) and that restraint 
(immobilization) stress on pro-oestrus inhibits ovulation (50,111). 
In view of the scarce literature on the effect of stress on reproduction in the 
intact cyclic female rat, we first investigated in this thesis the effect of different 
periods of restraint stress on pre-ovulatory surge profiles of gonadotropins in the 
5-day cyclic female rat and concomitant effects on ovarian histology (Chapter 
2). Additionally, experiments were performed to gain more insight in the mech-
anism underlying the restraint-induced inhibition of the surge of gonadotropins. 
Therefore, the role of several neuropeptides known to be released in the brain 
during conditions of stress was investigated. First, the effect of central admin-
istration of exogenous CRH in pro-oestrous rats was studied (Chapter 3). lev 
injections of CRH were given just before the presumed onset of the LH surge. 
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Also the effect was studied of infusions with CRH which were started before 
the presumed onset of the LH surge and continued until the beginning of the 
dark period thereby covering most of the period during which the surge appears. 
Because a role for AVP in mediating the effect of CRH on LH secretion is sug-
gested, rats were pretreated with an AVP-antiserum before administration of 
CRH. Subsequently, the role of CRH and AVP in the restraint-induced sup-
pression of the pro-oestrous LH surge was studied (Chapter 4). Therefore, 
restrained rats were pretreated with the CRH antagonist, a-helical CRH or with 
AVP-antiserum. 
A role for endogenous opioids as mediator in the inhibitory effect of stress on 
basal and pro-oestrous LH release has also been suggested. In Chapter 5, we 
studied the effect of pretreatment with the opioid antagonist, naloxone and its 
longer acting analog naltrexone on the inhibitory effect of restraint on the LH 
surge. 
Finally, GABA appears to be involved as inhibitory neurotransmitter in the 
regulation of GnRH release. During the application of several stressors the 
GABAergic system is altered. Since an interaction between the HPG axis and 
GABAergic modulation of the stress response have been hardly investigated, a 
possible involvement of GABA in the restraint-induced inhibition of the LH surge 
was studied by pretreatment with a GABAA and GABAB antagonist (Chapter 6). 
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Abstract 
Plasma profiles of luteinizing hormone (LH) and follicle stimulating hormone 
(FSH) were measured during restraint stress on the day of pro-oestrus; these 
profiles were considered in relation to ovulation rate on the next day. Rats 
bearing a permanent jugular vein cannula were subjected to restraint which was 
started 0, 1 or 2 h before the presumed onset of the LH surge and ended just 
before the beginning of the dark period. Exposure to restraint resulted in a 
suppression of the secretion of both gonadotropins on the day of pro-oestrus. 
Suppression of the LH surge was virtually complete (plasma LH < 0.2 ng/ml) in 
1 5 out of 32 stressed rats, and the ovaries of these rats contained graafian fol-
licles with oocytes in germinal vesicle stage. In these rats, the LH surge did not 
occur 24 h later. In the remaining 17 rats, restraint resulted in a considerable 
suppression of the LH surge. Of these rats, 5 had an ovulation rate of 100% 
and 4 ovulated partially. In unruptured follicles of the latter, the oocyte had not 
resumed meiosis and the follicle wall was not luteinized. In the remaining 8 rats 
with a reduced LH surge, ovulations had not occurred and graafian follicles were 
unaffected. The results of this study indicate that during pro-oestrus restraint 
stress suppresses and does not delay the release of preovulatory gonadotropins. 
Partial suppression of LH by restraint does not result in induction of meiotic 
resumption without subsequent ovulation or in luteinized unruptured follicles. 
Introduction 
Stress of physical or emotional origin may interfere with reproductive func-
tions (1,2). Stress can influence the release of gonadotropin releasing hormone 
(GnRH) (3) and so of luteinizing hormone (LH) and follicle stimulating hormone 
(FSH). Most studies have been performed in male or in ovariectomized female 
animals (4-6). Little research has been done into the effect of stress on the pro-
oestrous LH and FSH surge in intact female rats. In adult cyclic rats, unpre-
dictable footshocks applied on pro-oestrus caused a partial inhibition of the LH 
surge and of subsequent ovulation (7). After exposure to immobilization stress 
on the day of pro-oestrus ovulation was blocked and delayed for one day, imply-
ing also a delay of the LH surge by one day (8). 
In the intact female rat, the LH surge on the day of pro-oestrus triggers ovu-
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lation. LH also induces meiotic resumption of the oocyte and can induce prema-
ture luteinization in graafian follicles. In graafian follicles, meiotic resumption and 
luteinization have been shown to start after a dose of LH smaller than needed 
for ovulation (9,10). If restraint stress partially suppresses the LH surge, it may 
conceivably induce either meiotic resumption without subsequent ovulation or 
luteinized unruptured follicles (LUF). In the present study, we investigated the 
effect of restraint stress on preovulatory surge profiles of gonadotropins in rats. 
Different starting times of restraint on pro-oestrus were chosen with the aim of 
obtaining a variety of moderately to strongly reduced LH surge profiles. In these 
rats, we wanted to investigate whether a partially suppressed LH surge might 
induce meiotic resumption and/or luteinization without ovulation. To that end the 
ovaries were collected for histology the day after restraint. Occurrence of ovula-
tion, meiotic resumption without subsequent ovulation and LUF were studied in 
relation to the LH profiles. 
Materials and Methods 
Rats, housing and surgery 
The experiments were performed with female F1 hybrids (6-8 months of age, 
200-250 g body weight) of two Wistar substrains (U-inbred males and R-inbred 
females) from the University breeding colony. They were maintained in a con-
trolled temperature environment ( 2 2 ± 1 °C) with lights on from 0000 to 1400 h. 
With this light regimen these rats have 5-day cycles and the onset of the gona-
dotropin surge is at around 0900 h, i.e. 2 h after the middle of the light period 
(11). The rats were individually housed and received standard food pellets and 
tap water ad libitum. A dim light was left on during the dark period to facilitate 
blood sampling. 
Rats were provided with a jugular vein cannula according to the method of 
Steffens (12) with some modifications (13) under ketamine (40-60 mg/kg intra-
peritoneal) and xylazine (210 //I subcutaneous of a 2% solution diluted with 2 
volumes of saline) anaesthesia. Starting one day after surgery, the rats were 
handled daily to minimize stress during blood sampling. Oestrous cyclicity was 
assessed each day by inspection of vaginal smears and observation of lordosis 
behaviour induced after introduction of a male rat for a brief period in the cage. 
Rats that exhibited at least two consecutive 5-day cycles following surgery, 
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were used for experimentation. 
Restraint procedure 
After being connected to a blood sampling cannula, individual rats were 
placed in a perspex cylinder of 4.8 cm inner diameter. One end of the cylinder 
was cone-shaped and provided with perforations to facilitate air supply to the 
rat. The other end of the cylinder contained outlet-drains for urine and an open-
ing for the tail of the rat. A slit (0.7 cm wide) running along the length of the 
cylinder enabled fixation of a partition-wall to adjust the interior length of the 
cylinder to the size of the rat. The blood sampling cannula was exteriorized via 
the slit. 
Experimental protocol 
The experiments were conducted after approval by the University Committee 
on Animal Care and Use (DEC). 
Rats (2-5 rats at a time) were transferred to a novel experimental room and 
immediately placed in a restraint cylinder. The restraint was started at 0, 1 or 2 
h before the onset of the LH surge, which was anticipated to begin at approxi-
mately 0900 h. The rats were released and returned to their home cage shortly 
before the onset of the dark period at 1400 h. After a recovery period of two 
hours, oestrous behaviour (lordosis) was assessed by allowing a male into the 
cage. Blood samples were taken hourly from 0900 h up to 1700 h and also on 
the next day at 1100, 1200 and 1300 h. After the 1300 h sample the rats were 
anaesthetized by ether and killed by cervical dislocation. Ovaries were collected 
for histological examination. Controls were cannulated rats in pro-oestrus of 
which blood samples were taken hourly in their home cage from 0900 to 1700 
h and they were killed the next day at 1300 h. 
Radioimmunoassay 
Blood samples (150 p\) were collected in ice-cooled heparinized tubes. After 
centrifugation plasma samples (60 fj\) were diluted with 3 volumes of phos-
phate-saline buffer (pH 7.5) containing 0 . 1 % bovine serum albumin (Sigma RIA-
grade) and stored at -20°C. LH and FSH levels were measured, using kits pro-
vided by the NIDDK. rLH-RP-2 and rFSH-RP-2 diluted in serum of hypophys-
ectomized rats were used as reference materials. The second antibody was 
donkey-anti-rabbit (Sac-Cef, Wellcome Reagents, Beckenham, GB). Determina-
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tions were performed in triplicate. Quality control sera with low, medium and 
high LH or FSH concentrations were included in each RIA. Assay sensitivity at 
90% B/B„ was 0.05 ng/tube for LH and 0.4 ng/tube for FSH. In the diluted 
plasma samples, concentrations lower than 0.2 ng LH/ml and lower than 1.6 ng 
FSH/ml were considered as baseline levels. The intra-assay coefficients of 
variation for LH and FSH were 4 .3% and 5.7%, respectively. 
Histology 
Ovaries were fixed in Bouin's solution and embedded in paraffin wax. Serial 
sections (8-10 /vm) were stained with hematoxylin (Gurr, GB) and eosin and 
mounted in DePeX (Gurr, GB). In both ovaries of each rat, graafian follicles with 
or without meiotic resumption, luteinized unruptured follicles and ruptured 
follicles were counted; the latter were compact structures containing numerous 
dark-staining nuclei and these structures could easily be distinguished from 
corpora lutea of preceding cycles (for details see Mattheij et al., (9)). 
Statistical analysis 
LH and FSH peak values were based on the value from zero to maximum LH 
respectively FSH value. To compare the response curves of LH and FSH to re-
straint stress the individual data of the surge between 0900 and 1700 h were 
expressed as the area under the curve (AUC). The AUC is the integrated area 
between the baseline and the LH/FSH response above the baseline. The AUC of 
LH and FSH, the peak values of LH and FSH, and ovulation rate were analyzed 
by the Kruskal-Wallis test (one-way analysis of variance), with nonparametric 
comparisons made, using the Mann-Whitney U-test when trends were found to 
be significant. For statistical analyses the Statistical Program System for the 
Social Sciences (SPSS/PC + V2.0, SPSS, Inc., Chicago, ID was used. Sig-
nificance was defined at the 0.05 level. Values are reported as means ± SEM. 
Results 
Figure 1 illustrates the effect of restraint on plasma LH during pro-oestrus. In 
individual control rats, the peak value of LH ranged between 7.5 and 10.5 ng/ml 
and was reached between 1100 and 1400 h. In restraint rats, the highest 
plasma LH levels ranged between basal and 4.3 ng/ml. Exposure to restraint 
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Time of day (h) 
Fig. 1. Profiles of rat plasma LH during pro-oestrus: (D) controls (N = 8); (O) restraint 
0900-1400 h (N = 10); (A) restraint 0800-1400 h (N = 11); (•) restraint 0700-1400 h 
(N = 11 ). Black horizontal bar represents dark period; data are given as mean ± SEM. 
resulted in a significant inhibition of the LH response (peak value and AUC; both 
P<0.01 compared to controls) in all experimental groups. No significant overall 
differences were observed between the three groups with different starting 
times of restraint. 
A considerable variation of individual LH profiles was observed in all restraint 
groups. Restraint completely blocked the LH surge (plasma LH < 0.2 ng/ml) in 
15 out of 32 rats. In 10 rats, maximum LH levels varied between 0.5 and 1.7 
ng/ml. Maximum LH levels between 2.1 and 4.3 ng/ml were reached in 7 rats. 
Figure 2 illustrates LH profiles of 6 individual rats, in which restraint did not 
completely suppress the LH surge. In stressed rats suppressed maximum LH 
levels were reached at any time point between 0900 and 1600 h. The rat in 
figure 2b shows an advanced onset of the LH surge. In all restraint-stressed rats 
LH levels were low (0.2-0.4 ng/ml) on the next day at 1100, 1200 and 1300 h. 
This indicates that the restraint had not delayed the surge of LH by 24 h. 
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Time of day (h) 
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Time of day (h) 
Fig. 2. Release pattern of LH in six individual rats of which restraint suppressed the LH 
surge partially: (O; a, b) 5-h restraint; (A; c, d) 6-h restraint; ( • ; e, f) 7-h restraint. Black 
horizontal bar represents dark period. 
As shown in figure 3, in control rats plasma FSH increased gradually on the 
day of pro-oestrus and restraint significantly suppressed this gradual FSH rise 
(P<0.01). FSH was 2.9 ± 0.1 ng/ml at 1100, 1200 and 1300 h the day after 
pro-oestrus. No correlation was observed between the peak and AUC values of 
LH and FSH. 
In Table 1 the data on the ovaries, peak LH concentration in the plasma, 
relative amount of LH released during LH surge (AUC) and ovulation rate are 
given of controls and stressed rats. FSH data are not given because no correla-
tion was seen between ovulation rate and peak or AUC values of FSH. In control 
rats, virtually 100% ovulation had occurred. Ovulation rate was significantly 
reduced in the restraint groups (P<0.05). No significant differences were found 
between the three restraint groups with regard to ovulation rate, so they were 
considered as one group. In the 15 rats which had LH levels < 0.2 ng/ml, the 
graafian follicles were unaffected, i.e. they contained an oocyte with germinal 
vesicle and showed no luteinization. In 7 rats with a maximum LH level between 
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Fig. 3. Profiles of rat plasma FSH during pro-oestrus: (D) controls (N = 8); (O) restraint 
0900-1400 h (N = 10); (A) restraint 0800-1400 h (N = 11); (•) restraint 0700-1400 h 
(N = 11 ). Black horizontal bar represents dark period; data are given as mean ± SEM. 
0.5 and 1.7 ng/ml and an AUC between 0.4 and 3 .1 , the graafian follicles were 
also apparently unaffected. Exceptions were 2 rats with a maximum LH level of 
0.5 and 1.3 ng/ml and an AUC of 0.8 and 3.0 in which respectively 100% and 
17% of the graafian follicles had ovulated. Rats with a peak LH level > 2 ng/ml 
or an AUC of > 4.0 generally showed a high ovulation rate, with the exception 
of one rat with a peak level of 2.8 ng/ml and an AUC of 4.0 which had not 
ovulated. In rats with partial ovulation, most of the unruptured graafian follicles 
were unaffected. Very few luteinized unruptured follicles were observed; they 
contained an oocyte in metaphase-ll stage. 
A noteworthy trend was that the number of rats that had a relatively high LH 
peak, AUC and ovulation rate, was greater in the 6-h and 7-h restraint group 
than in the 5-h restraint group. 
On pro-oestrus all control rats and 70% of the stressed rats showed lordosis 
when a male was introduced in their home cage at 1600 h. 
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Discussion 
In male and ovariectomized female rats LH secretion is suppressed and the 
FSH secretion has been found not to be affected by various stressors (5,14-17). 
In the present study, exposure of cyclic rats to restraint on the day of pro-
oestrus resulted in a strong inhibition of both the LH and the FSH surge. Hülse 
and Coleman (7) observed a partial suppression of the LH surge in cyclic rats 
subjected to inescapable footshocks for 3 h during the surge on pro-oestrus. To 
the authors' knowledge, a suppressive effect of stress on the FSH surge of 
cyclic rats has not been reported before. A reduced FSH surge may conceivably 
cause a decrease of the number of ovulations in the next cycle. 
Transferring the rats to a novel experimental room before restraint may be an 
additional stressor. With respect to restraint stress the effect of novel environ-
ment on the LH surge is probably small because we observed no effect of mov-
ing the rats to a novel experimental room in pilot studies. 
Restraint totally blocked the LH surge in 15 rats. These rats did not have 
elevated LH and FSH levels the next day, indicating that the restraint had not 
delayed the surge of gonadotropins by one day. The complete absence of ovu-
lations and unruptured follicles containing an oocyte in metaphase indicates that 
in these rats no substantial gonadotropin secretion had occurred between the 
period of blood sampling on pro-oestrus and the sampling period on the next 
day. This corroborates the view that in the rat the preovulatory surge of LH 
occurs in a fixed period of the day relative to the light-dark cycle (18). 
In contrast to our results, Yonetani et al. (8) reported that forced immobiliza-
tion for 4 h starting at the beginning of the LH surge delayed the LH surge by 
one day. These discrepant results may be due to a strain-difference or may 
reflect a difference between the stress-model used, i.e. restraint in a cylinder 
versus tying up in a supine position. The preovulatory LH surge is blocked and 
delayed by 24 h in 4- and 5-day cyclic rats after injection of Nembutal on the 
day of pro-oestrus (19,20). After injection of Nembutal on pro-oestrus, LH and 
FSH are suppressed but oestradiol levels remain relatively high; apparently 
oestradiol remains sufficiently high to evoke an LH surge on the day after pro-
oestrus (21). In the present study, the absence of an LH surge on the day after 
restraint is hard to explain. It may have been caused by restraint-stimulated 
corticosterone secretion (22); increased corticosterone may inhibit FSH-induced 
aromatase activity and consequently oestrogen production in granulosa cells 
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(23). However the corticosterone increase during restraint is transient (24); it is 
unlikely that a relative brief rise of corticosterone caused a lasting suppression 
of oestrogen synthesis. Stress-induced suppression of gonadotropins might have 
caused atresia of follicles and so a decrease of oestrogen synthetic capacity. 
This is also unlikely because after Nembutal-induced suppression of gona-
dotropins an LH and FSH surge occurred the next day (21). 
Ovulation is initiated by a gonadotropin surge on the day of pro-oestrus; the 
magnitude of the LH surge is considerably larger than needed to cause full 
ovulation. Greig and Weisz (25) reported that approximately 14% of the peak LH 
value is sufficient to induce ovulation which agrees with the results of the 
present study. In the present study, it appears that also approximately 14% of 
the control AUC value is sufficient to trigger ovulation. The LH surge induces 
meiotic resumption of the oocyte in graafian follicles. In Nembutal-anesthesized 
rats, a dose-related effect of LH on meiotic resumption, luteinization and ovula-
tion was reported (9,10): injection of 1 fjg LH caused meiotic resumption but no 
ovulation; 2 fjg LH caused ovulation of some follicles and meiotic resumption 
plus luteinization but no ovulation of the other graafian follicles; 4 fjg LH caused 
more ovulations. Based on these data we expected that no ovulations but mei-
otic resumption with or without luteinization should have been induced in the rat 
with a small rise of LH during pro-oestrus. However the present data show that 
after a considerably reduced LH surge either all graafian follicles ovulated, or the 
graafian follicles appeared unaffected; they contained an oocyte in germinal 
vesicle stage and were not luteinized. The explanation of the discrepancy 
between Mattheij et al. (9,10) and the present results may be that in the former 
studies injection of LH caused a steep and short-lasting (less than 60 minutes) 
increase of LH in the plasma whereas in the present study the rats with a par-
tially suppressed LH surge had a slightly increased LH level for several hours. 
The discrepancy may also be due to the fact that Mattheij et al. (9,10) injected 
LH 8 h before the presumed onset of the LH surge. Conceivably at that time 
fewer LH receptors were present in the granulosa layer of the graafian follicles 
than at the beginning of the presumed onset of the LH surge (26). 
In the present study, 7 0 % of the stressed rats showed lordosis 2 h after the 
end of restraint while they had a reduced or totally suppressed LH surge. In the 
cyclic rat, oestradiol and progesterone (27,28) together wi th GnRH (29) initiate 
and intensify oestrous behaviour. In 1 5 rats, restraint completely suppressed the 
LH surge. So an increase of the GnRH secretion in the hypophyseal portal sys-
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tem and a consequent increase of ovarian progesterone did presumably not 
occur. Yet 13 of these rats showed lordosis. The elevated plasma oestrogen on 
pro-oestrus together with a stress-induced increase of the production of adrenal 
progesterone (27) or other adrenal steroids (30) may have induced lordosis in 
these rats. 
We conclude that restraint stress inhibited and did not delay gonadotropin 
secretion on pro-oestrus. Partial inhibition of LH secretion by restraint is not 
followed by induction of meiotic resumption without subsequent ovulation or by 
luteinized unruptured follicles. 
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Abstract 
The effect of intracerebroventricular (icv) injection or infusion of various doses 
of corticotropin-releasing hormone (CRH) on the LH and FSH surge was studied 
in pro-oestrous rats supplied with a jugular vein and an icv cannula. Additionally, 
we investigated if arginine vasopressin (AVP) was involved in the CRH-induced 
alterations to the surge of gonadotropins, lev injection of 10 //g CRH given 5 
min before the presumed onset of the LH surge caused a strong inhibition of the 
LH surge and a slight inhibition of the FSH surge. Three to four h after CRH in-
jection, its inhibitory effect diminished. A 6 h icv infusion of CRH started 1 h 
before the presumed onset of the LH surge, caused a dose-related inhibition of 
the LH and FSH surge. Infusion of 1 /vg/h CRH did not suppress the surge of 
both hormones while infusion of 5 or 10 /vg/h CRH inhibited the LH surge. Infu-
sion of 10 //g/h CRH caused a strong suppression of plasma LH during the first 3 
h of the LH surge. Despite continuation of CRH infusion, the inhibitory effect 
disappeared and plasma LH increased to similar levels as in controls at corres-
ponding points of time of the LH surge. The FSH surge was also suppressed by 
infusion of 10 //g/h CRH. The surge of LH and FSH was not affected by a 9 h 
infusion of 10 //g/h CRH started 4 h before the presumed onset of the LH surge. 
This observation also indicates that the inhibitory effect of CRH may last for 
only 3-4 h. The surge of LH and FSH was not affected by icv injections of AVP-
antiserum. However, pretreatment with AVP-antiserum prolonged the inhibitory 
effect of CRH on the LH surge. In conclusion, CRH can inhibit the pro-oestrous 
LH and to a lesser extent the FSH rise for only 3-4 h after the beginning of CRH 
administration. AVP may play a role in limiting the inhibitory effect of CRH on 
LH to 3-4 h. 
Introduction 
An important component of the adaptive response to stress is the activation 
of the hypothalamic-pituitary-adrenal (HPA) axis (1). A major neurohormonal re-
gulator of adrenocorticotropic hormone (ACTH) secretion from the pituitary is 
CRH. CRH is widely distributed within the central nervous system (2-4), indica-
ting that it is involved in brain functions other than the hypothalamic regulation 
of ACTH secretion (5). CRH also plays a role in modulating stress-induced inhi-
53 
bition of the hypothalamic-pituitary-gonadal (HPG) axis (6,7). lev administration 
of CRH to male or ovariectomized (OVX) rats resulted in inhibition of luteinizing 
hormone (LH) secretion (8-10), but not of follicle stimulating hormone (FSH) (8, 
9,11). Prolonged icv CRH administration decreased LH but not FSH secretion in 
male rats (12,13). Long-term administration of CRH can cause downregulation 
of pituitary CRH receptors (14,15) and also of brain CRH receptors (16). So, it is 
conceivable that continuous exposure of the brain to high CRH levels may alter 
the effect of CRH on the pro-oestrous LH and FSH surge. 
The central mechanisms mediating the CRH-induced suppression of gonado-
tropin secretion are only partly understood. Endogenous opioid peptides are 
involved in the inhibition of LH secretion by CRH (10,17-19). AVP may mediate 
the CRH-evoked ß-endorphin release from the hypothalamus (20). Additionally, 
intravenous (21) or icv (22) administration of AVP resulted in an inhibition of the 
pro-oestrous LH surge in cyclic rats. On the other hand, AVP may also contrib-
ute to downregulation of CRH receptors (23, 24). 
The present study aimed to assess to which extent icv injection or infusion of 
CRH can suppress the pro-oestrous surge of LH and FSH in cyclic rats. Also the 
effect of relatively long CRH infusion on the LH and FSH surge was examined. In 
addition, we investigated if an AVP-antiserum could modify the effect of CRH in-
jection or prolonged CRH infusion on the pro-oestrous surge of LH and FSH. 
Materials and Methods 
Rats, housing and surgery 
The experiments were performed with female F1 hybrids (6-8 months of age, 
200-250 g body weight) of two Wistar substrains (U-inbred males and R-inbred 
females) from the University breeding colony. They were maintained in a con-
trolled temperature environment (22±1°C) and at a photoperiod of 14 hours 
light per day (lights on at 0000 h). At this light regimen most of these rats have 
5-day cycles and the onset of the gonadotropin surge is at approximately 0900 
h (25). The rats were individually housed with free access to standard food pel-
lets and drinking water. A dim light was left on during the dark period to fa-
cilitate blood sampling. 
Preceding surgery, rats were anaesthetized with ketamine (40-60 mg/kg intra-
peritoneal) and xylazine (Rompun®, 1.4 mg/rat subcutaneous). They were fitted 
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with a silastic jugular vein cannula according to the method of Steffens (33) 
with some modifications (34), and an icv stainless steel cannula (23-gauche) in 
the right lateral ventricle (35). Starting two days after surgery, the rats were 
handled every day to minimize stress during blood sampling. In addition, oes-
trous cyclicity was monitored daily by vaginal lavage and observation of oes-
trous behaviour after introduction of a male rat in the cage. Oestrous cyclicity 
was assessed between 1200 and 1300 h preceding and during the experiments. 
Rats that exhibited at least two consecutive 5-day cycles following surgery, 
were used for experimentation. Correct location of the icv cannula was routinely 
checked after each experiment by injection of 3 p\ Evans blue solution (10% in 
saline) and macroscopic inspection of the ventricular system after decapitation. 
Only data obtained from rats with a correctly placed icv cannula were included 
in the analysis. 
Chemicals 
The compounds used were: Synthetic rat/human CRH (1-41); Sigma Chemical 
Company, St Louis, USA; MW: 4757.5; Arginine vasopressin (AVP)-antiserum 
(W3) raised in a rabbit at the Rudolf Magnus Institute, University of Utrecht, The 
Netherlands. It had no cross-reaction with oxytocin and des-glycinamide-vaso-
pressin, 6% with lysine vasopressin and 120% with vasotocin. These data were 
obtained under RIA conditions with iodinated AVP as competitor; AVP-antiserum 
(W3) was used at a concentration of 1:70.000. 
Saline (0.9%) served as solvent and control icv solution. AVP-antiserum and 
normal rabbit serum (NRS) used in the experiments were diluted with one vol-
ume of saline. All injections and infusions were given icv. Injections were given 
at a volume of 3 fjl using a 10/ / I Hamilton syringe; icv infusion rate was 26 //l/h 
using a Precidor'1 micro-infusion pump. 
Experimental Procedures 
The experiments were conducted after approval by the University Committee 
on Animal Care and Use (DEC) of the Wageningen Agricultural University. 
Experiment 1 : Effect of a single icv injection of CRH on the LH and FSH surge in 
pro-oestrous rats. 
CRH 0.1 or 10 fjg was administered in conscious, freely moving rats 5 min 
before the presumed onset of the LH surge (at 0900 h). Rats injected with saline 
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and untreated rats served as control. Blood samples were taken every half hour 
from the beginning of the LH surge to 30 min before the dark period. 
Experiment 2: Effect of icv infusion of CRH on the LH and FSH surge in pro-oes-
trous rats. 
A 6-hour infusion of 1, 5 or 10 //g/h CRH was given from 0800 to 1400 h. 
Blood samples were taken hourly from 0900 to 1600 h. Controls received a 6-
hour infusion of saline. In addition, a group of rats without infusion was 
included. 
Experiment 3: Effect of pretreatment with AVP-antiserum on the CRH-induced 
suppression of the plasma LH and FSH surge on pro-oestrus. 
This experiment consisted of 5 groups. The experimental design for this study 
is depicted in Table 1. Blood samples were obtained at 1 h intervals during the 
LH surge period (from 0900 to 1 700 h). 
TABLE 1 . Experimental Design of Experiment 3 
Group icv pretreatment at icv injection 
t = -24 h* and t = -0.5 h* at t = -5 min' 
saline 
saline 
saline 
^0/JQ CRH 
10/yg CRH 
"time before the presumed onset of the LH surge at 0900 h 
Experiment 4: Effect of 9 h icv infusion of CRH preceded by treatment with 
AVP-antiserum on the LH and FSH surge on pro-oestrus. 
Two injections of AVP-antiserum or NRS were given. The first injection was 
given 24 h and the second injection 4.5 h before the onset of the LH surge. 30 
Min after the second injection, a 9 h infusion of 10 //g/h CRH was started. The 
control group received two injections of saline but not a subsequent 9-hour 
infusion of saline. In pilot experiments we had found that prolonged infusion of 
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2 
3 
4 
5 
saline 
NRS 
AVP-antiserum 
NRS 
AVP-antiserum 
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saline did not influence the surge of gonadotropins. Blood samples were ob-
tained at 1 h intervals during the LH surge period. 
Radioimmunoassay 
Blood samples (160//I) were collected in heparinized tubes at 4°C. After cen-
trifugation, plasma samples (70 //I) were diluted with 3 volumes of phosphate-
saline buffer (pH 7.5) containing 0 . 1 % bovine serum albumin (Sigma RIA-grade) 
and stored at -20°C. LH and FSH levels were measured, using materials pro-
vided by NIDDK. rLH-RP-2 and rFSH-RP-2 diluted in serum of hypophysecto-
mized rats were used as reference materials. The first antibodies NIADDK-anti-
rLH-S-9 and NIADDK-anti-rFSH-S-11 were used at a final concentration of 
1:20.000 and 1:80.000, respectively. The second antibody was donkey-anti-
rabbit (Sac-Cef, IDS, Boldon, Type and Wear, England). Determinations were 
performed in triplicate. Quality control sera with low, medium and high LH or 
FSH concentrations were included in each RIA. Assay sensitivity of the diluted 
samples at 90% B/B„ was 0.2 ng/ml for LH and 1.6 ng/ml for FSH. The intra-
assay coefficients of variation for LH and FSH were 6 . 1 % and 5.4%, respect-
ively. The inter-assay coefficients of variation for LH and FSH were 5 . 1 % and 
11.5%, respectively. 
Statistical analysis 
The response curves of plasma LH and FSH were plotted separately for each 
rat. The peak height of a LH surge was calculated as the value from zero to the 
highest LH level measured. Plasma LH and FSH values were analyzed using a 
two-way analysis of variance with repeated measurements (MANOVA). Post hoc 
analyses (Bonferroni) were performed, if a positive interaction was found. For 
statistical analysis the Statistical Program System for the Social Sciences 
(SPSS/PC + V2.0, SPSS, Inc., Chicago, IL) was used. A probability of less than 
0.05 was considered significant. Values are reported as means ± SEM. 
Results 
Experiment 1. Effect of a single icv CRH injection on the LH and FSH surge in 
pro-oestrous rats. 
Fig. 1 shows the plasma LH and FSH surge and their time course following 
injection of saline or CRH. A dose of 0.1 or 10 /vg CRH or saline was injected 5 
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minutes before the presumed onset (at 0900 h) of the surge of gonadotropins. 
In saline-treated rats, the highest plasma LH value occurred at 1200 h with a 
maximal value of 11.0 ± 1.0 ng/ml (Fig. 1a). The LH surge of untreated rats 
was similar in amplitude and duration (data not shown). After injection of 0.1 //g 
CRH, the LH surge was similar as in saline-treated controls. Injection of 10 /vg 
CRH caused an inhibition of the LH surge (P<0.01) and peak height (P<0.01). 
LH was suppressed at most time points but at 1330 h plasma LH was similar as 
in the controls. 
In saline-treated control rats and in untreated rats (data not shown), plasma 
FSH increased gradually on the day of pro-oestrus (Fig. 1b). Injection of 0.1 //g 
CRH or 10 //g CRH did not affect this FSH rise. 
14-1 
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Fig. 1. Effect of 0.1 or 10 /yg CRH injected icv on the pro-oestrous LH (a) and FSH (b) 
surge in cyclic rats. Injections were given 5 min before the presumed onset (at 0900 h) 
of the LH surge. (•) saline (N = 10); (O) 0.1 ug CRH (N = 6); (•) 10^g CRH (N = 10). 
Values are expressed as means ± SEM. 
Experiment 2: Effect of icv infusion of CRH on the LH and FSH surge in pro-oes-
trous rats. 
Fig. 2a illustrates the effect of infusion of saline or 1, 5 or 10 fjg/h CRH from 
0800 to 1400 h on the LH surge. After infusion of saline the LH surge was 
similar as in untreated rats (data of untreated rats not shown). The LH surge 
was not influenced by infusion of 1 /yg/h CRH. CRH infusion of 5 /vg/h did not 
58 
Chapter 3 
14 
12 -
10 -
8 -
6 -
4 -
2 
0 
12 
- l 1 1 -
in 6 
Li-
(Ö 
E 
a 4 -
Q. 
2 -
rTj/ .J 
0900 1000 1100 1200 1300 1400 1S00 1600 
time (h) 
Fig. 2. Effect of icv infusion of various doses of CRH on the pro-oestrous LH (a) and 
FSH (b) surge in cyclic rats. Infusion was given during 6 hrs started 1 h before the 
presumed onset of the LH surge. (•) saline (N = 6); (0) 1 /jg/h CRH (N = 7); (V) 5 jug/h 
CRH (N = 7); (•) 10//g/h CRH (N = 7). Values are expressed as means ± SEM. The 
black horizontal bar represents the dark period. 
alter peak height but the total LH secretion during the surge was suppressed 
(P<0.01). Infusion of 10 / /g /h CRH strongly inhibited LH secretion (P<0.01); 
also peak height of the surge was suppressed (P<0.01). The inhibition of LH 
during infusion of 10 //g/h CRH lasted till 1200 h; subsequently plasma LH 
increased to control surge levels at corresponding points of time of the LH 
surge. The profile of the LH surge after icv infusion of 10/ /g/h CRH (Fig. 2a) is 
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comparable to the profile of the LH surge after single injection of 10 //g CRH 
(Fig. 1a and also Fig. 3a). 
As shown in Fig. 2b, in control rats plasma FSH increased gradually during in-
fusion of saline. In untreated rats, the FSH rise during pro-oestrus was similar 
(data not shown). Infusion of 1 //g/h CRH induced an increased FSH secretion 
(P<0.05). Infusion of 5 //g/h CRH did not affect FSH levels. Infusion of 10//g/h 
CRH caused a suppression of the FSH rise (P<0.01). 
Experiment 3. Effect of pretreatment wi th AVP-antiserum on the suppression of 
the LH and FSH surge induced by icv injection of 10 fjg CRH. 
The LH surge of the control group which received injections of normal rabbit 
serum (NRS) 24 h and 0.5 h before the onset of the LH surge, and saline at 
0855 h, had a profile of similar amplitude and duration (Fig. 3a) as the saline-
treated group of experiment 2 and as the saline-treated group of experiment 3 
(data not shown). After injections of AVP-antiserum instead of NRS, a similar LH 
surge profile was measured. In NRS-treated rats, injection of 10 //g CRH (at 
0855 h) caused a strong suppression of the LH rise during the first 3 hours of 
the surge (P<0.01). Thereafter LH increased to a similar level as in controls at 
corresponding points of time of the LH surge. In rats pretreated with AVP-anti-
serum, an injection of 10 //g CRH induced also a strong suppression of the 
plasma LH surge (P<0.01) and peak height (p<0.01) . After pretreatment with 
AVP- antiserum, the inhibitory action of CRH on the LH surge was prolonged. 
The AVP-antiserum plus CRH treatment resulted in lower mean levels of LH at 
1400 and 1 500 h compared to saline plus CRH injected rats. 
In the NRS-saline group, plasma FSH showed the expected gradual rise after 
0900 h on pro-oestrus (Fig. 3b). AVP-antiserum induced an inhibition of FSH 
levels (P<0.05). In NRS-pretreated rats, 10 pg CRH caused a suppression of the 
FSH rise (P<0.01). This suppression was not altered after pretreated with AVP-
antiserum. 
Experiment 4 : Effect of 9 h icv infusion of 10 //g/h CRH preceded by treatment 
with AVP-antiserum on the LH and FSH surge. 
In experiment 2, we had found that during continuous infusion of 10 //g/h 
CRH the LH-suppressive effect of CRH was attenuated 3-4 h after the start of 
infusion. To confirm this observation in experiment 4, a 9 h CRH infusion was 
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Fig. 3. Effect of pretreatment with AVP-antiserum on the CRH-induced suppression of 
the pro-oestrous LH (a) and FSH (b) surge in cyclic rats. Injections of AVP-antiserum or 
NRS were given icv 24 h and 0.5 h before the presumed onset of the LH surge; 10 pg 
CRH or saline was given icv 5 min before the onset of the LH surge. (•) NRS + saline 
(N = 7); (D) AVP-antiserum + saline (N = 6); (•) NRS + -\0 ug CRH (N = 7); (O) AVP-
antiserum + 10/yg CRH (N = 8). Values are expressed as means ± SEM. The black 
horizontal bar represents the dark period. 
an LH surge as in the control group despite continued infusion until 1400 h. Fig. 
4a illustrates that indeed the LH surge was not suppressed, if the 9 h infusion of 
CRH was started at 0500 h. Treatment with AVP-antiserum preceding CRH infu-
sion caused a considerable suppression of the LH surge compared to the control 
(P<0.01) and the CRH-infusion group (P<0.01). While plasma LH was strongly 
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Fig. 4. Interaction of AVP-antiserum and icv infusion of 10 fjg/b CRH on the pro-oes-
trous surge of LH (a) and FSH (b) in cyclic rats. Saline or AVP-antiserum was icv injec-
ted 24 h and 4.5 h before the presumed onset of the LH surge. 10 fjg/h CRH was 
infused during 9 hrs, starting at 0500 h. (•) saline (N = 7); (•) saline + 10/yg/h CRH 
infusion (N = 6); (O) AVP-antiserum + 10/yg/h CRH infusion (N = 5). Values are ex-
pressed as means ± SEM. The black horizontal bar represents the dark period. 
suppressed during the first hours of the surge, at 1400 h plasma LH had 
increased to the control level of 1400 h. 
Fig. 4b shows that the pro-oestrous FSH rise was neither altered by prolonged 
infusion of 10 /vg/h CRH nor by CRH infusion after pretreatment wi th AVP-anti-
serum. 
62 
Chapter 3 
Discussion 
Various stressors inhibit the secretion of gonadotropins (6,25,26). A role for 
CRH in inhibiting reproductive functions during stress has been suggested (6,7). 
lev injection of CRH caused an inhibition of plasma LH in male and OVX rats (8-
10,12,13). Also in pro-oestrous rats, LH levels were inhibited by icv CRH (8, 
10). The present study confirms this and demonstrates that central administra-
tion of CRH induced a dose-dependent inhibition of the plasma LH surge on the 
day of pro-oestrus. In addition we found that the suppressive effect of CRH on 
the LH surge was limited to 3-4 hrs. It is conceivable that in previous studies in 
pro-oestrous rats (8,10) plasma LH levels were not measured long enough after 
icv CRH administration to observe a possible decrease of the inhibitory effect of 
CRH. 
In experiment 1, the diminishing inhibitory effect of CRH on plasma LH 3-4 h 
after CRH injection could possibly be due to degradation of the administered 
CRH. To verify this hypothesis we gave an icv infusion of various doses of CRH 
(experiment 2). Despite continuation of CRH infusion until 1400 h, a release 
from CRH inhibition of plasma LH occurred after 3-4 h of infusion. 
In experiment 2, 3 and 4, blood sampling was extended into the dark period. 
In this way we could assess the descending phase of the LH surge in controls, 
and also if a postponed LH surge of normal magnitude occurred after release 
from CRH inhibition. The data indicate that a postponed LH surge of normal 
magnitude did not occur. This corroborates the view that in the rat the pro-
oestrous LH surge can occur only during a limited period of the day (25,27). 
The present results show that during pro-oestrus the inhibiting effect of CRH 
on the LH surge was restricted to 3-4 h. This may conceivably due to down-
regulation of brain CRH receptors by continuous high local concentrations of 
CRH. Recently, Hauger et al. (16) reported that high central levels of CRH re-
sulted in downregulation of CRH receptors in the amygdala of male rats. Support 
for the hypothesis that brain CRH receptors are downregulated, is further pro-
vided by the observation of experiment 4 that a 9 h CRH infusion started 4 h 
before the presumed onset of the LH surge did not interfere with the LH and 
FSH surges. However, other studies reported that the number of CRH receptors 
in the central nervous system was not changed if high central CRH levels were 
induced (14,24,28). Another possibility for the release from CRH inhibition could 
be that an unknown stimulatory pathway is activated which overrules the CRH 
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inhibition. Considering the results of the present study, AVP may be involved in 
this stimulatory pathway. 
As far as the FSH data are concerned, conclusions on the effects of CRH on 
the pro-oestrous FSH rise were difficult to draw. This is partly due to the long 
half-life of plasma FSH (29). In addition, the FSH rise on pro-oestrus is not very 
steep and unexplainably plasma FSH was relatively high in some experimental 
groups at the start of the FSH rise. Generally CRH tended to inhibit the FSH rise 
of pro-oestrus. In experiment 2, however during infusion of 1 jt/g/h CRH plasma 
FSH was higher than in controls. We do not have an explanation for this ob-
servation. Whereas AVP antiserum alone did not influence plasma LH, FSH 
levels were suppressed, suggesting a differential action of AVP on both gona-
dotropins. However, the difference between plasma FSH levels in saline- and 
AVP antiserum-treated rats could also be explained by the relatively high FSH 
levels at the presumed beginning of the FSH rise in saline-treated rats. 
In the present study, pretreatment with an AVP-antiserum did not prevent the 
CRH-induced inhibition of the LH and FSH surge. This result does not confirm 
our hypothesis that the inhibitory effect of CRH on the activity of the HPG axis 
is mediated by AVP. Our hypothesis was based on the observation of Burns et 
al. (20) that AVP mediated the effect of CRH on ß-endorphin release from the 
hypothalamus; opioids are involved in the CRH-induced inhibition of the HPG 
axis in male (17-19), OVX and OVX oestrogen-treated rats (10). The discrep-
ancy with Burns et al. (20) can be due to the fact that they studied slices of 
male hypothalamic tissue, while we studied intact cyclic female rats on the day 
of pro-oestrus. In addition, as far as we know an involvement of AVP in the 
CRH-induced inhibition of the pro-oestrous LH and FSH surge of cyclic rats has 
hitherto not been described. 
After pretreatment with AVP-antiserum the CRH induced inhibition of the LH 
surge lasted longer than 3-4 h. Additionally, in rats pretreated with AVP-anti-
serum the LH surge was suppressed during prolonged CRH infusion started 4 h 
before the presumed onset of the LH surge. AVP-antiserum injections per se had 
no effect on the LH and FSH surge. These results might indicate a possible 
stimulatory effect of AVP on GnRH but only during conditions of high central 
CRH levels. This is supported by the observation that icv administered AVP-anti-
serum prevented ether stress-induced LH release in OVX rats (30). On the other 
hand, there is evidence for an inhibitory effect of AVP on LH secretion, lev or in-
travenous (iv) administration of high doses of AVP has been reported to cause 
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suppression of the LH surge in cyclic rats (21,22), while iv infusions of AVP 
suppressed the steroid-induced surge of LH in OVX rats (31). However, these 
studies were performed under conditions with conceivably low central CRH 
release. Another explanation for our results is that pretreatment with AVP-anti-
serum prevented the downregulation of brain CRH receptors which possibly is 
induced by high central CRH levels. Various studies reported a contribution of 
AVP in the CRH-induced downregulation of CRH receptors in the pituitary (23, 
24,32). It is possible that AVP also stimulates CRH-induced downregulation of 
CRH receptors in the brain. So, mutatis mutandis, AVP-antiserum may have 
prevented the CRH-induced downregulation of CRH receptors. According to this 
hypothesis, LH should remain suppressed as long as CRH was infused into rats 
pretreated with AVP-antiserum. However, in experiment 4 LH was rising during 
the last hour of CRH infusion. We have no plausible explanation for this observa-
tion. The suppression may be overriden by a not-AVP-mediated stimulatory 
mechanism. 
In summary, we have shown that icv injection or infusion of CRH suppressed 
the LH and FSH surges on the day of pro-oestrus. This inhibitory effect of CRH 
is not mediated by AVP. On the contrary, administration of AVP-antiserum 
seemed to prolong the LH-suppressive effect of CRH. 
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Abstract 
The present study was designed to investigate the role of corticotropin-releasing 
hormone (CRH) and arginine vasopressin (AVP) in the inhibitory effect of 
restraint stress on the LH surge in intact, 5-day cyclic rats. Groups of rats were 
subjected to restraint stress for 5 or 6 hrs starting 5 or 60 min prior to the pre-
sumed onset of the surge. In restraint rats, the surge was partially inhibited as 
compared to non-stressed controls. Intracerebroventricular (icv) pretreatment 
with 10 or 30 fjg of the CRH antagonist ot-helical CRH (ahCRH) at 15 min before 
the application of restraint for 5 hrs did not affect LH levels in restraint and 
control rats during the period of the surge, but partially prevented the plasma 
corticosterone response induced by restraint. Pretreatment of rats (icv) with 
AVP-antiserum 24 h before the onset of the LH surge and 0.5 h before applica-
tion of restraint potentiated the restraint-induced suppression of pro-oestrous LH 
levels, but did not influence the LH surge in non-stressed control rats. An intra-
venous (iv) injection with 100 ng Ovalyse®, a GnRH agonist, during restraint res-
ulted in a steep and transient rise of plasma LH levels indicating that the pitu-
itary was not rendered refractory to GnRH. 
From these data, we conclude that CRH pathways that are activated during 
restraint stress do not mediate the stress-induced inhibition of the pro-oestrous 
LH surge in the intact, cyclic rat. In addition, the results suggest that the resid-
ual LH surge observed during restraint is dependent on stress-induced 
vasopressin activity in the brain. 
Introduction 
Stress-induced endocrine responses include activation of the hypothalamus-
pituitary-adrenal (HPA) axis and inhibition of the hypothalamus-pituitary-gonadal 
(HPG) axis. Evidence for stress-induced inhibition of the HPG axis mainly derives 
from studies on male and ovariectomized female rats (1-4), but it has been 
shown that footshock (5) and, more recently, restraint stress (6) can suppress 
the pro-oestrous LH surge in intact cyclic female rats. 
The mechanisms responsible for stress-induced suppression of the surge of 
the HPG axis are not clearly understood. Observations that CRH is released dur-
ing stress (7) and that central administration of CRH largely mimics the 
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behavioral and physiological effects observed during stress (8) suggest that CRH 
may be a mediator of this stress response. Indeed, there is experimental evid-
ence that CRH, acting within the hypothalamus, inhibits the HPG axis (9-13). 
We have shown recently that administration of CRH before the onset of the 
pro-oestrous LH surge, can suppress the surge in cyclic female rats (14). Even 
with high doses of CRH, however, this inhibition was only partial and restricted 
to the first phase of the surge. Moreover, we found that icv pretreatment with 
AVP-antiserum extended the inhibitory effect of CRH (14). From this, it was 
concluded that during conditions of high central CRH activity, vasopressin 
pathways are activated that mitigate the inhibition of LH secretion. Indeed, sev-
eral studies suggest a role of AVP in control of LH secretion during stress (15-
17). 
In the present study we investigated the role of CRH and AVP in the restraint 
stress-induced inhibition of the pro-oestrous LH surge in intact cyclic female 
rats. 
Materials and Methods 
Rats, housing and surgery 
All experiments were carried out on adult female F1 rats of two Wistar sub-
strains (U-inbred males and R-inbred females), weighing 200-250 g. The rats 
were individually housed under a 14:10 h light-dark schedule (lights on at 00:00 
h) in a temperature-regulated (22 ± 1 °C) room. They had free access to stand-
ard food pellets and tap water. A dim light was left on to facilitate blood 
sampling during the dark period. Under these circumstances most of these rats 
have 5-day oestrous cycles and the onset of the pro-oestrous LH surge is ap-
proximately at 0900 h (6). 
Rats were provided with a silastic jugular vein cannula (18) and a stainless 
steel icv cannula (23 gauche) into the right lateral ventricle (19). For surgery, 
rats were anaesthetized with ketamine (40-60 mg/kg ip) and xylazine (Rompun*, 
1.4 mg/rat sc). Starting two days after surgery, the rats were handled daily to 
minimize stress during blood sampling. In addition, oestrous cyclicity was mon-
itored every day by vaginal lavage, and by observation of oestrous behaviour 
after introduction of a male rat. Rats that exhibited at least two consecutive 5-
day cycles were used in the experiments. On termination of the experiments, 
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correct icv cannula placement was checked after injection of 3 //I solution of 
Evans blue (10% in saline) and macroscopical inspection of the brain. Data ob-
tained from rats with an incorrectly placed icv cannula were discarded. 
Drugs 
The compounds used were a-helical CRH (9-41), a CRH receptor antagonist 
(Sigma Chemical Company, St Louis, USA), Ovalyse* (des10-GnRH-ethylamide), a 
GnRH agonist (gift from Upjohn, Ede, the Netherlands) and AVP-antiserum (code 
W3). The antiserum displayed no cross-reaction with oxytocin, 6% with lysine 
vasopressin and 120% with vasotocin (tested under radioimmunoassay condi-
tions). 
Saline (0.9%) served as solvent and control solution. AVP-antiserum was di-
luted with one volume of saline. A previous experiment had shown that there 
was no difference between icv injections with saline and normal rabbit serum 
(NRS) on the LH surge. The icv injections with saline, othCRH or AVP-antiserum 
were given in a volume of 3 //I using a 10 //I Hamilton syringe. Ovalyse" was 
given iv in a volume of 0.2 ml. 
Experimental Procedures 
The experiments were conducted after approval by the University Committee 
on Animal Care and Use of the Agricultural University Wageningen. 
Restraint procedure 
On the day of pro-oestrus, rats were connected to a blood sampling cannula 
approximately 1 h before application of restraint stress. They were transferred 
to the experimental room just before the onset of restraint. Restraint was 
accomplished by placing individual rats in a perspex cylinder (see for more 
details ref. 6) and was started at 0855 or 0800 h, i.e. 5 or 60 min before the 
presumed onset of the LH surge at 0900 h. The rats were released and returned 
to their home cage after taking the blood sample at 1400 h. 
Experimental design 
Experiment 1 
Pro-oestrous rats were subjected to restraint stress from 0855 h to 1400 h. 
15 Min before the onset of restraint, they were icv injected with 10 or 30 yg 
ahCRH, or saline. Non-stressed rats received 30 PQ ahCRH or saline. Blood 
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samples of 160 JJ\ were taken hourly during the period of the LH surge, i.e. from 
0900 to 1700 h. 
To investigate pituitary responsiveness to GnRH during restraint, a group of 
stressed rats was included which received an iv injection with 100 ng Ovalyse* 
after withdrawal of the blood sample at 1200 h. 
Experiment 2 
Rats were placed in a restraint cylinder for 5 hrs (from 0855 h to 1400 h). 
They received an icv injection with either AVP-antiserum or saline 24 h before 
the onset of the presumed LH surge and a second injection 0.5 h before the 
start of restraint. This protocol was repeated with rats subjected to 6 hrs of re-
straint (from 0800 to 1400 h). Non-stressed rats received injections with saline 
or AVP-antiserum. Blood samples (160/vl) were taken hourly from 0900 to 1700 
h. 
Radioimmunoassays 
LH assay 
Blood samples were collected in heparinized tubes on ice. After centrifugation, 
plasma samples (70 fj\) were diluted with 3 volumes of phosphate-saline buffer 
(pH 7.5) containing 0 . 1 % bovine serum albumin (Sigma RIA-grade) and stored at 
-20°C. LH levels were measured, using material provided by NIDDK. rLH-RP-2 
diluted in serum of hypophysectomized rats was used as reference material. The 
second antibody was donkey-anti-rabbit (Sac-Cef, IDS, Boldon, Type and Wear, 
England). Determinations were performed in triplicate. Quality control sera with 
low, medium and high LH concentrations were included in each RIA. In the 
assays, the least detectable amount of LH in the diluted samples was 0.2 ng/ml. 
The intra-assay and inter-assay coefficients of variation were 5.5% and 6 . 1 % , 
respectively. 
Corticosterone assay 
Corticosterone was extracted from 10 //I of the diluted plasma samples with 
dichloromethane, dried over night, resuspended in ethanol (96%) and stored at 
-20°C. Before determination, the samples were dried under nitrogen and dis-
solved in phosphate-saline buffer (pH 7.4). Corticosterone levels were measured 
using a corticosterone standard (Sigma C-2505) as reference, the anti-corticos-
terone i906 (UCB-bioproducts, Veenendaal, The Netherlands) which displayed 
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no cross-reaction with progesterone, and [1,2,6,7-H3] corticosterone (Amersham 
TRK 406) as tracer. The assay sensitivity was 2.8 /vg/100 ml, and coefficients 
of variation within and between assays were 4 .5% and 15.2%, respectively. 
Statistical analysis 
For statistical analysis the Statistical Program System for the Social Sciences 
(SPSS/PC + V2.0, SPSS, Inc., Chicago, IL) was used. LH and corticosterone 
data were analyzed using a MANOVA (two- or three-way analysis) with re-
peated measurements, which was followed by post hoc comparisons (Bonfer-
roni) if a positive interaction was found. Comparisons between individual groups 
for LH peak heights (i.e. the highest LH level measured), LH and corticosterone 
levels at different points of time were assessed by ANOVA and the Mann 
Whitney rank sum test. A probability of less than 0.05 was considered signific-
ant. Values are reported as means ± SEM. 
Results 
The effect of pretreatment with ochCRH on the restraint-induced suppression 
of the LH surge in pro-oestrous rats is shown in Fig. 1a. Comparison of the 
experimental groups, revealed a treatment effect (F = 8.3; P<0.01) and a treat-
ment x time interaction (F = 1.8; P<0.05) . 
The LH surge of non-stressed rats pretreated with 30 jjg ahCRH was similar 
to the LH surge of saline-pretreated rats. Restraint stress for 5 hrs (starting at 
0855 h) partially inhibited LH levels during the period of the LH surge (P<0.01). 
Pretreatment with 10 jug ochCRH did not affect LH levels in restraint rats. How-
ever, the plasma LH profile of restraint rats pretreated with 30 /ug ahCRH dif-
fered from those of saline-pretreated restraint rats (P<0.01). LH levels of re-
straint rats pretreated with 30 //g ochCRH were lower than those of saline-
pretreated restraint rats at 1000 h (P<0.01) and 1100 h (P<0.05). Thereafter 
they increased until 1500 h at which they were significantly higher than in sa-
line-pretreated restraint rats (P<0.05). When during restraint an iv injection of 
Ovalyse" was given (at 1200 h) a steep, robust and transient rise of plasma LH 
was observed (Fig. 1b). Plasma LH levels were increased at 1300 and 1400 h 
(P<0.01) compared to untreated restraint rats. 
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time (h) 
Fig. 1. Effect of ahCRH (a) and Ovalyse* (b) on the restraint-induced suppression of the 
pro-oestrous LH surge. Rats were pretreated (icv) with saline or ahCRH at 0840 h, and 
were subjected to restraint from 0855 until 1400 h. Ovalyse* was iv injected in 
restraint rats at 1200 h. (•) saline (n = 14); (D) 30/ /g ahCRH (n = 6); (•) saline + 
restraint (n = 14); <±) 10//g ahCRH + restraint (n = 7); (V) 30 pg ahCRH + restraint 
(n = 8); (O) restraint + 100 ng Ovalyse* (n = 6). Values are expressed as means ± SEM. 
Black horizontal bar represents the dark period of the lighting cycle. 
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Fig. 2 illustrates the effect of pretreatment with ahCRH on corticosterone 
levels in restraint rats. Comparison of the experimental groups, revealed a treat-
ment x time interaction (F = 2.5; P<0.05) . Restraint stress induced an increase 
of corticosterone during the first 2 hrs after the start of restraint compared to 
non-stressed rats (P<0.05). In restraint rats pretreatment with 10 or 30 fjg 
ahCRH partially prevented this response. At 1000 and 1100 h corticosterone 
levels in restraint rats pretreated with the CRH antagonist were neither different 
from those of non-stressed saline-pretreated rats nor saline-pretreated restraint 
rats. In non-stressed rats, administration of 30 fjg ahCRH had no effect on cor-
ticosterone levels as compared to saline pretreatment. 
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Fig. 2. Effect of ahCRH on the restraint-induced rise of plasma corticosterone. Rats 
were icv pretreated with saline or ahCRH at 0840 h, and were subjected to restraint 
from 0855 until 1400 h. (•) saline (n = 7); (D) 30 fig ahCRH (n = 6); (•) saline + 
restraint (n = 7); (*•) 10 fjg ahCRH + restraint (n = 7); (V) 30 fig ahCRH + restraint 
(n = 8). Values are expressed as means ± SEM. Black horizontal bar represents the dark 
period of the lighting cycle. 
Fig. 3 illustrates the effect of pretreatment with AVP-antiserum on the re-
straint-induced suppression of the LH surge. The three-way analysis revealed a 
significant restraint effect (F = 49.5; P<0.01) , a restraint x time interaction 
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(F = 7.7; P<0.01) , and an AVP-antiserum x time interaction (F = 3.0; P<0.05) . 
The LH surge of non-stressed rats which received injections of saline or AVP-
antiserum 24 and 0.5 h before the presumed onset of the LH surge did not differ 
from those of saline-pretreated rats (Fig. 3). As in experiment 1, restraint sup-
pressed LH levels during the period of the surge (P<0.01). Pretreatment with 
AVP-antiserum led to a further reduction of plasma LH levels compared to sa-
line-pretreated restraint rats (P<0.05 from 1200 to 1500 h). 
Previous experiments had shown that restraint for 6 hrs starting at 0800 h 
was less effective in suppressing LH levels during the period of the LH surge 
than restraint for 5 hrs starting at 0855 h. Also in rats subjected to this protocol 
pretreatment with AVP-antiserum potentiated the restraint-induced suppression 
of the LH surge (P<0.05; data not shown). 
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Fig. 3. Effect of pretreatment with AVP-antiserum on the restraint-induced suppression 
of the pro-oestrous LH surge. Rats were subjected to restraint from 0855 to 1400 h. 
Pretreatment consisted of icv injections of saline or AVP-antiserum at 24 h before the 
presumed onset of the LH surge and at 0.5 h before the start of restraint. (•) saline 
(n = 13); (D) AVP-antiserum (n = 6); (•) saline + restraint (n = 10); (O) AVP-antiserum + 
restraint (n = 7). Values are expressed as means ± SEM. Black horizontal bar represents 
the dark period. 
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Discussion 
The present data that restraint stress can suppress the pro-oestrous LH surge 
in intact cyclic female rats corroborate previous findings from our own group (6, 
14,20) and others (5). Treatment of the rats, during restraint, with an iv bolus 
of the GnRH agonist Ovalyse" induced a marked plasma LH response, indicating 
that the stress had not rendered the pituitary refractory to GnRH. This accords 
with data from others who, in addition, have provided evidence that central 
mechanisms regulating GnRH secretion are crucially involved in the effects of 
stress on the HPG axis in male (21-23) and intact female rats (24,25). Taken 
together, it is therefore most likely that the inhibitory effect of restraint stress 
on the LH surge is brought about via neural pathways that affect the secretion 
of GnRH into the portal system. In view of literature data on the role of CRH in 
stress responses (8,13,26-28), and our own previous results that neither endo-
genous opioid (20) nor GABA (Roozendaal et al., unpublished) systems mediate 
the effect of restraint, we considered the CRH system the prime candidate in 
this respect. 
Contrary to our expectations, however, pretreatment of rats with ahCRH (10 
or 30 fjg, icv) did not antagonize the inhibitory effect of restraint on the LH 
surge, suggesting that endogenous CRH does not play a crucial role in this 
effect. One could argue, however, that the relevant site(s) in the brain had not 
been reached by sufficient amounts of the antagonist, but for various reasons 
this does not seem to be very likely. Firstly, the stress-induced corticosterone 
response of the same rats was partly antagonized, indicating that under the 
experimental conditions and in the doses used, ahCRH had been centrally effect-
ive indeed. Secondly, ahCRH is a peptide closely related to CRH, and icv admin-
istration of CRH, in doses similar to or even considerably lower than those used 
here for the antagonist, suppresses the LH surge (14). Thirdly, the highest dose 
of ahCRH (30 ug) did have an effect in stressed rats, but potentiated rather than 
antagonised the initial effect of restraint stress. Since icv administration of CRH 
itself suppresses the LH-surge (14), this potentiation might be explained by 
some agonistic activity that has been shown to reside in the antagonist (29; 
Dr.E.Ronken, personal communication). Finally, there are numerous studies 
reporting on effects of icv administration of ahCRH, often in doses lower then 
those used in this study, on a wide variety of behavioral and physiological 
responses involving sites throughout the brain (8,30). Therefore we conclude 
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that not CRH, but other factors in the brain likely mediate the effect of restraint 
stress on the pro-oestrous LH surge in the intact female rat. 
Rivier et al. (13) have shown that footshock stress suppresses LH levels in 
castrated male rats, and that this effect is antagonized by icv pretreatment with 
100/yg othCRH. This apparent discrepancy with our present results could be due 
to differences in the stress protocol employed, or in hormonal regulation and 
state between the rats used, i.e. castrated male versus intact cyclic female rats. 
An alternative explanation, however, could be that ahCRH shares with CRH the 
ability to activate vasopressinergic mechanisms in the brain that can enhance LH 
secretion (14), and thereby counteracted the stress-induced inhibition. Such 
'agonistic' properties most likely become overt when high doses are used. 
In saline-pretreated rats subjected to restraint stress a residual LH surge was 
observed. In rats pretreated with an AVP-antiserum, however, restraint stress 
completely abolished the surge. This strongly suggests, that the residual LH 
surge is maintained by an action of endogenous AVP that is released during 
stress. There is considerable evidence, indeed, that various stressors, including 
acute and repeated restraint, induce vasopressin mRNA-expression, peptide syn-
thesis, storage and secretion in hypothalamic neurons. These concern not only 
parvocellular neurons in the paraventricular nucleus (PVN) (31-37), but most 
likely also magnocellular vasopressin neurons in PVN and the supra-optic nucleus 
(35, 38, 39). In addition, the enhanced release of AVP into the circulation that 
occurs following restraint is probably of magnocellular origin (40). Sofar, how-
ever, the exact type and location of the vasopressin neurons, as well as the site 
of release and action of the vasopressin that is involved in the present effect on 
LH secretion remain to be elucidated. Yet, it is of interest in this respect, that 
we have recently obtained first lightmicroscopical immunocytochemical evidence 
for the presence of a vasopressin-containing fibre input on a small subset of 
GnRH containing neurons in the medial preoptic and anterior hypothalamic area, 
that may thus provide an anatomical substrate for vasopressin interaction with 
the hypothalamus-pituitary-ovarium axis (van der Beek and Wiegant, unpub-
lished). Whatever its origin and locus of action during stress in this respect, 
vasopressin apparently does not play an important role in maintaining the surge 
under normal, non-stressed conditions, since pretreatment with the AVP-
antiserum did not affect the surge in non-stressed control rats. 
In conclusion, the present data indicate that the partial inhibition of the pro-
oestrous LH surge induced by restraint stress in intact cyclic female rats is likely 
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not mediated by CRH. In addition, the results provide first evidence that the 
residual surge maintained during restraint is dependent on stress-induced 
vasopressin activity in the brain. Since such a residual LH-surge appears to be 
sufficient for triggering ovulation (6), the activation of vasopressin may be an 
adaptive mechanism to safeguard reproductive functions in the female rat during 
stress and hardship. 
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Abstract 
The effects of intravenous (iv) administration of the opioid antagonists naloxone 
and naltrexone on the restraint-induced suppression of the pro-oestrous LH 
surge were studied in cyclic female rats. To minimize stress during repeated 
blood sampling, the rats were provided with a jugular vein cannula. Restraint 
stress for 6 hrs starting at t = -1 h (the onset of the LH surge being at t = 0 h) 
caused a suppression of LH levels (including peak height) during the period of 
the LH surge. Repeated naloxone injections, given 3 h (1 mg), 4 h (0.5 mg) and 
5 h (0.5 mg) after the onset of the LH surge, did not affect the restraint-induced 
inhibition neither did pretreatment with 1 mg naloxone at t = -75 min (i.e. 15 min 
before application of restraint). Naltrexone (2 mg) administered at t = -15 min in-
duced higher plasma LH levels at t = -6 min. When rats were subsequently sub-
jected to restraint for 5 hrs starting at t = -5 min, the restraint-induced inhibition 
of surge levels of LH was not affected. The results indicate that withdrawal of 
opioid activity in cyclic female rats before the presumed onset of the LH surge 
results in a premature rise of LH levels. This is in accordance with the notion 
that LH levels prior to the surge are under tonic inhibition of endogenous opioid 
peptides (EOP). In addition, the data show that opioid receptor antagonism dur-
ing or before application of restraint does not alter the restraint-induced suppres-
sion of the LH surge. It is therefore concluded that EOP do not mediate the in-
hibitory effect of restraint stress on the LH surge in cyclic rats. 
Introduction 
In cyclic rats, the preovulatory LH and FSH surge occurs on the afternoon of 
pro-oestrus as a consequence of increased hypothalamic GnRH secretion into 
the hypophysial portal system. The role of EOP in the control of GnRH secretion 
has been studied extensively (1-3). Administration of morphine or ß-endorphin 
inhibits the spontaneous or induced preovulatory surge of gonadotropins in 
female rats, the effect being more pronounced for LH than FSH secretion (4-8). 
In addition, a decrease of the inhibitory EOP tone on the afternoon of pro-oes-
trus plays a role in the induction of pre-ovulatory GnRH secretion in the rat 
(9,10). The ß-endorphin concentration in hypothalamic tissue and pituitary portal 
blood varies during the oestrous cycle with low levels at the time of the LH 
87 
surge (9,10). Moreover, blockade of EOP receptors by administration of the 
opioid receptor antagonist naloxone before the onset of the LH surge elicits a 
premature LH surge (11). 
Several studies have suggested a modulatory role for EOP in the effects of 
stress on reproductive parameters but only a few have used intact female rats. 
Naloxone administered 1 5 min before the onset of restraint can reverse the anti-
ovulatory action of restraint in immature female rats primed with pregnant mare 
serum gonadotropin (PMSG) (12). Footshock stress applied during the period of 
the LH surge results in inhibition of LH release which can be antagonized by nal-
oxone administration 5 min prior to application of the stressor (13). In a previous 
study we demonstrated that on the day of pro-oestrus restraint stress can sup-
press the LH surge in intact cyclic rats (14). This suppression is believed to res-
ult from an impairment of hypothalamic hypophysiotropic function, since pituit-
ary responsiveness to GnRH is not affected by restraint (submitted for publica-
tion). 
The aim of the present study was to distinguish between a possible role of 
opioids in mediating the restraint-induced inhibition of the pro-oestrous LH surge 
vs. the role of endogenous opioids in the cyclic control of LH secretion in the 
intact female rat. 
Materials and methods 
Rats, housing and surgery 
Female F1 of U-male and R-female substrains of Wistar rats from the Univer-
sity breeding colony were used. They were 6-8 months of age and had a body 
weight of 200-250 g. The rats were individually housed in standard conditions 
of temperature (22±1°C) and lighting (14L:10D). During the dark period a dim 
light was left on to facilitate blood sampling. Food pellets and drinking water 
were provided ad libitum. Most of our rats have 5-day cycles and the onset of 
the LH surge is approximately 2 h after the middle of the light period (14); this 
time was defined as t = 0 h. 
Preceding surgery, rats were anaesthetized with ketamine (40-60 mg/kg in-
jected ip) and xylazine (Rompun®, 1.4 mg/rat injected sc). The rats were pro-
vided with a silastic jugular vein cannula (15). Starting two days after surgery, 
the rats were handled daily to minimize stress during blood sampling. Daily 
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vaginal lavages were obtained and oestrous behaviour was observed after in-
troduction of a male rat in the cage. Only rats exhibiting at least 2 consecutive 
5-day cycles before experimentation were included in the study. 
Chemicals 
The opioid receptor antagonists, naloxone hydrochloride (Sigma Chemical 
Company, St Louis, USA; MW 363.8) and naltrexone (Sigma Chemical Com-
pany, St Louis, USA; MW 377.9) were given iv. Naloxone and naltrexone were 
dissolved in 0.2 ml saline (0.9%); controls received 0.2 ml saline. 
Experimental Procedures 
The experiments were approved by the Committee on Animal Care and Use of 
the Agricultural University of Wageningen. 
Restraint procedure 
At pro-oestrus, rats were connected to a blood sampling cannula and 1 h later 
they were transferred to the experimental room. Rats were subjected to restraint 
stress by placing them individually in a perspex cylinder at t = -1 h (exp 1 and 2) 
or at t = -5 min (exp 3), i.e. 1 h and 5 min respectively before the presumed 
onset of the LH surge at t = 0 h (for more details see ref. 14). The rats were re-
leased and returned to their home cages at t = 5 h. 
Exp 1. Effect of naloxone administration during restraint on the LH surge. 
Rats subjected to restraint from t = -1 to t = 5 h received naloxone or saline iv 
at t = 3 h (1 mg) and at t = 4 and t = b h (0.5 mg). Non-stressed rats receiving 
saline served as controls. Blood samples (160 fj\) were taken hourly during the 
LH surge period from t = 0 to t = 8 h. 
Exp 2. Effect of pretreatment with naloxone on the restraint-induced sup-
pression of the LH surge. 
Rats received 1 mg naloxone or saline iv at t = -75 min (i.e. 15 min preceding 
the onset of restraint). The rats were subjected to 6 hrs of restraint stress 
starting at t = -1 h. Non-stressed rats receiving saline served as controls. Blood 
samples were taken hourly from t = 0 to t = 7 h. 
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Exp 3. Effect of naltrexone on the restraint-induced suppression of the LH surge. 
In this experiment we tried to minimize the influence of opioid antagonism on 
the pro-oestrous GnRH-releasing mechanism. To extend the duration of the 
opioid receptor blockade and to avoid a premature onset of the LH surge, nal-
trexone (2 mg/rat) or saline was iv injected at t = -15 followed by restraint for 5 
h which was started at t = -5 min. Non-stressed rats received naltrexone or sa-
line at t = -15 min. A blood sample was taken just before application of restraint 
to determine a premature rise of plasma LH and subsequently blood samples 
were taken hourly from t = 1 to t = 8 h. 
Radioimmunoassay 
Blood samples were collected in heparinized tubes on ice. After centrifugation, 
plasma samples (70 fj\) were diluted with 3 volumes of phosphate-saline buffer 
(pH 7.5) containing 0 . 1 % bovine serum albumin (Sigma RIA-grade) and stored at 
-20°C. Plasma LH values were expressed as ng/ml in terms of LH-RP-2 which 
was diluted in serum of hypophysectomized rats. NIADDK-anti-rLH-S-9 antisera 
was used at a final concentration of 1:20.000. Donkey-anti-rabbit (Sac-eel, IDS, 
Boldon, Type and Wear, England) was used as second antibody. Determinations 
were performed in triplicate. Quality control sera with low, medium and high LH 
concentrations were included in each RIA. The detection level of the LH assay 
for diluted blood samples was 0.2 ng/ml at 9 0 % B/B„ level. The intra-assay and 
inter-assay variation for LH were 5.5% and 10.0%, respectively. 
Statistical analysis 
The response curves of plasma LH were plotted separately for each rat. LH 
data were analyzed using a MANOVA (two- or three-way analysis) with re-
peated measurements followed by post hoc analyses (Bonferroni) if a positive in-
teraction was found. Each experimental group was defined as a separate treat-
ment. One-way analyses of variance followed by the Mann Whitney-U test, if 
appropriate, was used for comparing values of peak height (i.e. the highest LH 
level measured) and values of different groups at given times. For statistical ana-
lysis the Statistical Program System for the Social Sciences (SPSS/PC + V2.0, 
SPSS, Inc., Chicago, IL) was used. Differences were considered significant at a 
level of P<0 .05 . Values are reported as means ± SEM. 
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Results 
Fig. 1 shows the effect of iv naloxone or saline injections given during re-
straint. In non-stressed rats the onset of the LH surge was at t = 0 h and a max-
imum LH level of 9.0 ± 1.0 ng/ml was reached at t = 3 h, after which LH levels 
decreased to basal at t = 8 h. Comparison of the three experimental groups 
revealed a treatment effect (F = 7.5; P<0.01) and a treatment x time interaction 
(F = 3.7; P<0.01) . Post hoc analysis showed, that LH levels (including peak 
height) during the entire period of the LH surge in saline- and naloxone-treated 
restraint rats were suppressed compared to non-stressed controls (P<0.01). No 
significant differences were found between saline- and naloxone-treated restraint 
groups. 
- 1 0 1 2 3 4 5 
0 0 0 
Û naloxone injection 
rza restraint period 
Fig. 1. Effect of naloxone administration during restraint on the LH surge in pro-oes-
trous rats. During restraint from t = -1 to t = 5 h, naloxone or saline was iv injected at 
t = 3 h (1 mg naloxone) and at t = 4 and t = 5 h (0.5 mg naloxone). (•) saline (N = 10); 
(•) restraint + saline (N = 7); (O) restraint + naloxone (N = 10). Values are expressed as 
means ± SEM. The black horizontal bar represents the dark period. 
Fig. 2 illustrates the effect of naloxone administered 15 min prior to applica-
tion of restraint for 6 h starting at t = -1 h. A significant treatment effect 
(F = 5 .1 ; P<0.05) and a treatment x time interaction were observed (F = 2.2; 
P<0.05). Saline pretreated restraint rats had reduced LH levels (including peak 
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tZ3 restraint period 
- 1 0 1 2 3 4 5 
0 *//»////w/wi///w>»w//ww//w/n 
6 7 
time (h) 
Fig. 2. Effect of pretreatment with naloxone (1 mg) or saline at t = -75 min on the re-
straint-induced suppression of the LH surge. Rats were subjected to restraint for 6 hrs 
starting a t t = -1 h. (•) saline (N = 10); (A) saline + restraint (N = 9); (A) naloxone + re-
straint (N = 7). Values are expressed as means ± SEM. The black horizontal bar repres-
ents the dark period. 
height) during the entire surge period as compared with non-stressed controls 
(P<0.01). LH levels in naloxone pretreated restraint rats differed from those of 
control rats only at t = 4 h (P<0.01) and t = 5 h (P<0.05), but not from saline 
pretreated restraint rats. 
The effect of pretreatment wi th naltrexone on the restraint-induced suppression 
of the LH surge is depicted in Fig. 3. A significant effect of restraint (F = 19.6; 
P<0.01) and a restraint x time interaction (F = 4.8; P<0.01) were found. Re-
straint for 5 hrs starting at t = -5 min induced a suppression of LH levels (includ-
ing peak height) during the entire period of the LH surge as compared to controls 
(P<0.01). Pretreatment with naltrexone at t = -15 min did not significantly 
affect the LH surge in non-stressed controls and restraint rats, although in both 
naltrexone-treated groups the LH levels during the first hours appeared higher as 
compared to their saline counterparts. Naltrexone pretreatment induced signific-
antly higher LH levels at t = -6 min as compared to saline-treated rats (1.7 ± 0.2 
vs 1.0 ± 0 . 1 ; P<0.01) . 
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Fig. 3. Effect of pretreatment with naltrexone (2 mg) or saline at t = -15 min on the re-
straint-induced suppression of the LH surge. Rats were subjected to restraint for 5 hrs 
starting at t = -5 min. The first blood sample was taken at t = -6 min. (•) saline (N = 14); 
( • ) saline + restraint (N = 14); (D) naltrexone (N = 6); (0) naltrexone + restraint (N = 8). 
Values are expressed as means ± SEM. The black horizontal bar represents the dark 
period. 
Discussion 
In the present study, we have examined the influence of the administration of 
opioid antagonists on the LH response to restraint stress. In agreement with 
previous studies (14,16,17), exposure to restraint resulted in an inhibition of the 
pro-oestrous LH surge in cyclic female rats. The inhibitory effect of restraint was 
not antagonized by iv injections of naloxone from 4 hrs after the initiation of re-
straint. Thus, the inhibition of the LH surge by restraint may not be due to 
activation of opioid systems, or could no longer be counteracted by naloxone 
injections given after the onset of restraint. A decline in opiate sensitivity during 
the LH surge period has been suggested since morphine (8) and naloxone (18) 
administration were not effective when given after initiation of the oestrogen 
progesterone-induced LH surge in OVX rats. Morphine or ß-endorphin injections 
given before the onset of the LH surge, however, inhibit the spontaneous or 
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steroid-induced LH surge (4-8) suggesting that EOP exert an inhibitory action be-
fore the onset of the surge. Therefore, naloxone and naltrexone were subse-
quently given before the onset of restraint stress. 
The results demonstrate that pretreatment with naltrexone induced elevated 
LH levels before the presumed onset of the LH surge. This confirms the results 
of other studies which report an immediate release of LH after administration of 
naloxone or naltrexone (11,18-20). It is generally assumed that in cyclic rats ex-
cept for the period of the LH surge, EOP exert a tonic inhibitory influence on 
GnRH and LH secretion throughout the oestrous cycle (9,11,20). On the day of 
pro-oestrous, a premature decrease in opioid tone by naloxone administration 
can initiate an LH surge (11). In restraint rats pretreated with naloxone, the LH 
levels during the first 3 hrs of the surge were not different from those of con-
trols whereas those of saline pretreated restraint rats were. This may be attrib-
uted to a premature rise of plasma LH or to a partial blockade of the restraint ef-
fect on the surge. The former possibility seems most likely since pretreatment 
with naltrexone (experiment 3), like naloxone, did not significantly affect the 
restraint-induced suppression of the LH surge but raised LH levels significantly at 
t = -6 min (i.e. at a time point before the stress was applied), and appeared to 
elevate LH levels during the first phase of the surge. 
Many studies have suggested an opioidergic involvement in stress-related 
inhibition of gonadotropins in male and ovariectomized rats (21-25). The few 
available studies using intact female rats, have also suggested a role of opioids 
in the stress-induced inhibition of reproductive function in the intact female rat. 
Naloxone pretreatment reversed the anti-ovulatory effect of restraint in PMSG-
primed female rats (12), and temporarily antagonized the footshock stress-in-
duced inhibition of LH surge levels in pro-oestrous rats (13). It can not be ex-
cluded, however, that naloxone may have evoked a premature rise of LH by 
blockage of the inhibitory opioid tone also in these studies, because it was ad-
ministered 15 and 5 min respectively before the presumed onset of the LH 
surge. Moreover, it is known that even slightly elevated plasma LH levels on pro-
oestrus can induce ovulation (14). In accord with the present data, the results 
cited above may thus be explained by a premature LH surge induced by the 
naloxone treatment, rather than by antagonism of the effects of increased EOP 
release induced by stress. 
In summary, the present study shows that the inhibitory effect of restraint on 
the surge of LH was not affected by pretreatment with naloxone or naltrexone. 
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This indicates that opioids are not involved as mediators in the inhibitory effect 
of restraint stress on the LH surge in the cyclic rat. In addition, withdrawal of 
EOP inhibition before the presumed onset of the LH surge resulted in elevated 
LH levels, suggesting an involvement of EOP in the initiation of the surge. 
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Abstract 
There is evidence that stress can alter the activity in the brain of gamma-
aminobutyric acid (GABA), a neurotransmitter that has been implicated in the 
regulation of LH secretion. In the present study the role of GABA in the restraint 
stress-induced inhibition of the LH surge was investigated in the intact cyclic 
rat. Intracerebroventricular (icv) administration of the GABAA receptor agonist 
muscimol (0 .1 , 0.5 or 1 /vg) 5 min before the presumed onset of the pro-oes-
trous LH surge (at 0900 h) caused a dose dependent suppression of the surge. 
A single dose of the GABAB receptor agonist baclofen (1 /vg; icv) injected at 
0855 h postponed the onset of the LH surge, and repeated injections at 0855 
and 1130 h suppressed the surge. These data indicate that GABAergic activity 
in the brain can inhibit the LH surge in the cyclic rat via GABAA and GABAB 
receptors. Pro-oestrous rats were subjected to 5 hrs of restraint starting at 0855 
h. Pretreatment with the GABAA receptor antagonist bicuculine (1 fjg; icv) at 
0840, 0940 and 1040 h or pretreatment with the GABAB receptor antagonist 
phaclofen (10 /vg; icv) at 0840 h were ineffective in preventing the restraint-
induced inhibition of the LH surge. The results suggest that GABAA and GABAB 
receptors are not involved in the inhibitory effect of restraint stress on the LH 
surge. 
Introduction 
Restraint stress suppresses the surge of gonadotropins in intact female rats 
(1-3). Stressors can induce significant alterations in the activity of various 
neurotransmitter systems in the central nervous system (4), but the mechanisms 
underlying this effect of restraint have not been resolved sofar. 
GABA is a major inhibitory neurotransmitter in the brain. Under non-stress 
conditions, it plays an important role in the regulation of the GnRH release from 
the hypothalamus (5-8). GnRH neurons are under negative feedback regulation 
by oestrogen, but they do not contain oestrogen receptors (9). It has been pro-
posed that GABA neurons, located in the medial preoptic area mediate this neg-
ative feedback action (10-12), since they contain oestrogen receptors (8,11-15). 
Indeed, the actions of GABA depend on the steroidal milieu and the phase of the 
oestrous cycle (16-18). In addition, a decrease in GABAergic activity precedes 
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the oestradiol-induced LH surge in ovariectomized rats (19), and GABA release 
in the preoptic hypothalamic region decreases coincident wi th the oestrogen-
induced LH surge in ovariectomized rats (11,20,21). 
Several studies using male rats have reported an involvement of GABA in be-
havioural changes induced by stress (22,23). Additionally, various stressors can 
induce alterations in the GABA content and/or turnover in several areas of the 
brain (4,23-26). An increase in hypothalamic GABA content has been reported 
after immobilization or ether stress (4,23,25). Little notice has been paid to the 
involvement of GABA in the effects of stress on the activity of the 
hypothalamus-pituitary-gonadal axis. 
In the present study the effect of icv administration of the specific GABAA re-
ceptor agonist muscimol and GABAB receptor agonist baclofen on the pro-oes-
trous LH surge in intact female rats was determined. In addition, the effect of 
pretreatment with bicuculline, a specific GABAA receptor antagonist, and with 
phaclofen, a specific GABAB antagonist on the restraint-induced suppression of 
the pro-oestrous LH surge was investigated. 
Materials and Methods 
Rats, housing and surgery 
Adult female F1 rats (200-250 g) of U-male and R-female substrain Wistar 
rats from the University breeding colony were used. They were individually 
housed under controlled conditions of temperature (22 ± 1 °C) and lighting 
(14L:10D; lights on at 0000 h). Food and water were available ad libitum. At 
this light regimen most of our rats have 5-day cycles and the onset of the LH 
surge is approximately at 0900 h (1). During the dark period a dim light was left 
on to facilitate blood sampling. 
Under ketamine and xylazine anaesthesia, cyclic rats were provided with a 
silastic jugular vein cannula and a stainless steel icv cannula into the right lateral 
ventricle (2,27,28). After surgery, the rats were handled daily to minimize stress 
during blood sampling. Daily, oestrous cyclicity was determined by microscop-
ical rating of vaginal smears and by observation of oestrous behaviour after in-
troduction of a male rat. Only rats showing at least 2 regular 5-day cycles were 
used for the experiments. After the experiments, icv cannula placement was 
examined by injection of 3 //I solution of Evans blue (10% in saline) and ma-
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croscopical inspection of the brain after decapitation. Only data obtained from 
rats with a correctly placed icv cannula were used for analysis. 
Chemicals 
Muscimol, bicuculline, baclofen and phaclofen were purchased from Sigma 
Chemical Company, St Louis, USA. The drugs were dissolved in 0.9% saline 
and administered icv in a volume of 3 / / I . 
Experimental Procedures 
The experiments were approved by the Committee on Animal Care and Use of 
the Agricultural University of Wageningen. 
Restraint procedure 
Pro-oestrous rats were connected to a blood sampling cannula and transferred 
to the experimental room 1 h later. The rats were then individually subjected to 
restraint stress for 5 hrs in a perspex cylinder starting at 0855 h (for more de-
tails see ref. 1). The rats were released and returned to their home cages at 
1400 h. 
Effect of GABA agonists 
The following treatment groups were studied: (1) control rats injected icv with 
saline at 0855 h; (2) rats injected icv with 0 . 1 , 0.5 or 1.0 /jg muscimol at 0855 
h; (3) rats injected icv with 1 //g baclofen at 0855 h, or at 0855 and 1130 h. 
Blood samples were taken at regular time intervals during the period of the LH 
surge (from 0900 to 1400 h or to 1700 h). 
Effect of restraint stress and pretreatment with GABA antagonists 
Rats received icv 1 fjg bicuculline or 10 pg phaclofen at 0840 h, followed by 
restraint stress from 0855 to 1400 h. Bicuculline (1 fjg) injections were repeated 
at 0940 and 1040 h. Non-stressed rats receiving saline, bicuculline or phaclofen 
served as controls. Blood samples were taken hourly during the LH surge period 
(from 0900 to 1700 h). 
Radioimmunoassay 
Blood samples (160 JJ\) were collected in heparinized tubes on ice. After cen-
trifugation, plasma samples (70 fj\) were diluted with 3 volumes of phosphate-
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saline buffer (pH 7.5) containing 0 . 1 % bovine serum albumin (Sigma, RIA-grade) 
and stored at -20°C. LH levels were measured by radioimmunoassay, using 
materials provided by NIDDK. rLH-RP-2 diluted in serum of hypophysectomized 
rats was used as reference material. The second antibody was donkey-anti-rab-
bit (Sac-Cef, IDS, Boldon, Type and Wear, England). Determinations were 
performed in triplicate. Quality control sera with low, medium and high LH con-
centrations were included in each assay. The detection level of the assay for di-
luted blood samples was 0.2 ng/ml at 90% B/B0 level. The intra-assay and inter-
assay variation for LH were 5.8% and 5.9%, respectively. 
Statistical analysis 
For statistical analysis the Statistical Program System for the Social Sciences 
(SPSS/PC + V2.0, SPSS, Inc., Chicago, IL) was used. LH data were analyzed 
using a MANOVA (two-way or three-way analysis) with repeated measurements 
followed by post hoc analyses (Bonferroni) if a positive interaction was found. 
Each experimental group was defined as a separate treatment. One-way analysis 
of variance followed by the Mann Whitney-U test, if appropriate, was used for 
comparing values of peak height (i.e. the highest LH level measured) and values 
of different groups at given times. Differences were considered significant at a 
level of P<0.05 . Values are reported as means ± SEM. 
Results 
Effect of icv administration of GABA agonists on the pro-oestrous LH surge 
Fig. 1 illustrates the effect of icv administration of different doses of the 
GABAA agonist muscimol on the LH surge. Comparison of the four experimental 
groups revealed a treatment effect (F = 11.8; P<0.01) and a treatment x time 
interaction (F = 2.2; P<0.01) . In the group of rats treated with 0.1 fjg muscimol 
mean LH levels showed a partial inhibition of the LH surge (P<0.05). Notably, 
two rats in this group showed a normal LH surge. The other three showed com-
plete inhibition of LH secretion until at least 1300 h. In the group treated with 
0.5 fjg muscimol, the inhibition was complete in all rats until 1200 h (P<0.01), 
after which plasma LH levels started to increase. This delayed onset of the LH 
surge varied from 1200 to 1400 h. After 1 /jg muscimol the LH surge was sup-
pressed in all rats during the entire sampling period (P<0.01). 
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Fig. 1. Effect of icv injection of graded doses of the GABAA receptor agonist muscimol 
at 0855 h on the pro-oestrous LH surge. (•) saline (n = 11 ); (O) 0.1 jt/g muscimol (n = 5); 
(•) 0.5 fjq muscimol (n = 7); (A) 1 yt/g muscimol (n = 8). Values are expressed as means 
± SEM. 
The effect of icv treatment with the GABAB agonist baclofen, on the LH surge 
is represented in Fig. 2. A significant treatment effect (F = 6 . 1 ; P<0.05) and a 
treatment x time interaction (F = 2.6; P<0.05) was found. Administration icv of 
a single dose of 1 /vg baclofen at 0855 h suppressed LH surge levels until 1200 
h (P<0.01); subsequently plasma LH increased to control surge levels, resulting 
in a delayed surge with LH levels that were higher than controls at 1500 h 
(P<0.05). Repeated injections with 1 /vg baclofen at 0855 and 1130 h sup-
pressed the LH surge (P<0.01). 
Effect of restraint stress and icv pretreatment with GABA antagonists on the 
pro-oestrous LH surge 
Groups of rats were icv pretreated with saline, bicuculline or phaclofen and 
subjected to restraint from 0855 to 1400 h (Fig. 3). Comparison of the experi-
ental groups revealed a significant treatment effect (F = 9.9; P<0.01) and a 
treatment x time interaction (F = 2.4; P<0.01) . In non-stressed rats the LH surge 
after saline-treatment was similar to the surge of bicuculline- or phaclofen-
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Fig. 2. Effect of icv injection(s) of 1 fjg baclofen (GABAB receptor agonist) on the pro-
oestrous LH surge. (•) saline at 0855 h (n = 7); (0) baclofen at 0855 h (n = 4); ( • ) bac-
lofen at 0855 and 1130 h (n = 8). Values are expressed as means ± SEM. The black 
horizontal bar represents the dark period of the lighting cycle. 
treated rats (Fig.3; phaclofen data not shown). Saline-pretreated restraint rats 
had reduced LH levels during the period of the surge as compared with non-
stressed controls (P<0.01). Neither pretreatment with the GABAA antagonist 
bicuculline, nor pre-treatment with the GABAB antagonist phaclofen did alter the 
restraint-induced inhibition of the LH surge in the intact female rat. 
Discussion 
First aim of the present study was to determine whether activation of central 
GABA mechanisms during the pro-oestrous LH surge can inhibit the surge in the 
intact female rat. The data show that the LH surge can be postponed or in-
hibited by administration of the GABAA receptor agonist muscimol, and the 
GABAB receptor agonist baclofen as well. These data accord with those 
obtained by others in ovariectomized or ovariectomized/steroid-primed females 
that were icv treated with muscimol or baclofen (29-33). Moreover, they are in 
106 
Chapter 6 
14 
12-
~ 10-
E 
S 8 
I 
1 1 1 1 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 
0900 1000 1100 1200 1300 1400 1500 1600 1700 
time (h) 
Fig. 3. Effect of icv pretreatment with bicuculline (GABAA receptor antagonist) or 
phaclofen (GABAB receptor antagonist) on the restraint-induced suppression of the pro-
oestrous LH surge. Rats received saline at 0840 h, 1 //g bicuculline at 0840, 0940 and 
1040 h, or 10 /yg phaclofen at 0840 h, and were subjected to restraint stress from 
0855 to 1400 h. (•) saline (n = 14); (D) bicuculline (n = 6); (•) saline + restraint 
(n = 14); (A) bicuculline + restraint (n = 7); (*) phaclofen + restraint (n = 7). Values are 
expressed as means ± SEM. The black horizontal bar represents the dark period of the 
lighting cycle. 
line with the notion that a decrease in GABAergic activity is a prerequisite for 
initiation of the LH surge (19). 
In rats treated with low doses of muscimol (0.1 and 0.5 fjg), LH levels were 
initially inhibited and thereafter started to increase, indicating a delay in the 
onset of the LH surge. Similarly, a single injection with baclofen resulted in a 
delayed onset of the surge. This temporary inhibition cannot be explained by a 
shift during the 'surge period' in the sensitivity of GABA mechanisms regulating 
gonadotropin release, since a higher dose of muscimol and repeated injections of 
baclofen completely inhibited LH secretion during the entire sampling period. The 
temporary effects thus likely relate to the biological half-life of the drugs. Yet, 
kinetic data to substantiate this notion have not been reported to our know-
ledge. 
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Since GABA is a major inhibitory neurotransmitter in the brain and plays an 
important role in the regulation of the GnRH release, we hypothesized that it 
might be involved in the restraint-induced suppression of the LH surge. The pres-
ent study showed, however, that neither pretreatment with the GABAA receptor 
antagonist bicuculline, nor with the GABAB receptor antagonist phaclofen, antag-
onized the inhibitory effect of restraint on the LH surge. This strongly suggests 
that the restraint-induced inhibition of the LH surge is not mediated by GABAA 
receptors nor by GABAB receptors. 
It has been suggested (7) that oscillating GABA activity in the period before 
the onset of the surge may be the synchronizing signal which triggers GnRH 
release into the portal vessels. In accord with this notion, it has been shown 
that in ovariectomized rats hypothalamic GABA concentrations fall before the 
onset of a steroid-induced LH surge (11,20). In addition, a 3 h infusion of the 
GABA antagonist bicuculline from 4 to 1 h before the presumed onset of the 
surge advanced the onset of the pro-oestrous LH surge, whereas a 3 h infusion 
started 5 h before the presumed onset of the surge, did not affect the onset of 
the surge (21). From these data it is inferred that during a critical period of 2-1 h 
before the onset of the LH surge, GABA activity prevents a premature increase 
of LH levels. Indeed, in the present study, non-stressed rats pretreated with 
bicuculline (or phaclofen) 20 min before the presumed onset of the surge, 
showed no premature LH surge. Thus, our results can not be explained from 
interference of the pretreatment with GABA antagonists with GABA activity 
involved in the cyclic control of the LH surge. 
It has been proposed that, like GABA, endogenous opioids are also involved in 
the negative feedback action of oestrogen on GnRH release (34-37). Indeed, we 
have recently found that withdrawal of endogenous opioid activity in cyclic 
female rats before the presumed onset of the LH surge results in a premature 
rise of LH levels (3). In addition, several studies have suggested a role of endo-
genous opioids in the inhibitory effect of stress on reproduction but only a few 
studies have been performed with intact female rats (38,39). However, we have 
recently demonstrated that (pre)treatment with the opioid receptor antagonists 
naloxone or naltrexone did not affect the inhibitory effect of restraint on the pro-
oestrous LH surge in intact cyclic rats, indicating that endogenous opioids are 
not crucially involved in this effect (3). 
We conclude that, although the pro-oestrous LH surge can be inhibited by 
exogenous administration of GABAA and GABAB agonists, it is unlikely that 
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activation of GABA receptors mediates the inhibitory effect of restraint stress on 
the pro-oestrous LH surge. 
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Summary and conclusions 
The influence of stress on reproductive functions has been subject of much 
research. Various kinds of stress are known to affect reproductive functions. In 
females, the complex regulation of the ovarian cycle relies on a series of 
neuroendocrine events whose temporal relationship is so critical that any disruption 
in the orderly sequence may jeopardize reproductive success. During the oestrous 
cycle, especially the mechanisms which induce oestrous behaviour, the LH and FSH 
surge and ovulation seem to be vulnerable to stress. The evidence that stress 
influences reproductive functions is mainly based on studies performed with intact 
and castrated male rats, and with ovariectomized and ovariectomized, oestrogen-
primed female rats, and mainly concern the effect of stress on basal LH secretion. 
The hormonal status of these animal models differs essentially from those of intact 
pro-oestrous female rats, and this can of course be of influence on the response to 
the stressor. However, only a few studies have been performed on the effects of 
stress on the surge of gonadotropins in the intact cyclic female rat. This thesis 
focusses on the effect of restraint stress on the surge of gonadotropins and 
ovulation in the intact cyclic female rat and the underlying mechanisms. 
In Chapter 1 a review is given of stress and reproductive functions. In addition, 
possible pathways via which stress may influence reproduction are briefly 
discussed. 
Chapter 2 describes experiments on the effects of different periods of restraint 
stress on preovulatory LH and FSH surge profiles and ovulation in the intact cyclic 
female rat. In literature, the few studies performed with intact female rats have 
shown that: 1 ) the LH surge and subsequent ovulation are suppressed by footshock 
stress (1), and that ovulation is inhibited by immobilization stress (2,3); 2) the 
gonadotropin surge can be delayed by one day if on pro-oestrus the surge is 
blocked (3-5), and 3) a partially suppressed LH surge can induce alterations in the 
ovulation process, since treatment of rats of which the endogenous LH surge is 
blocked with a small amount of LH on the morning of pro-oestrus can cause meiotic 
resumption and induce precocious follicle luteinization (6,7). In the experiments 
described in chapter 2, groups of pro-oestrous rats were subjected to restraint 
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which was started 0, 1 or 2 h before the presumed onset of the LH surge and 
continued during the surge until the beginning of the dark period, thereby covering 
most of the period during which the surge appears. The presumed onset of the LH 
surge is approximately 2 h after the middle of the light period (8). Exposure to 
restraint resulted in a partial or total inhibition of the LH and FSH surge (no 
significant difference between the three restraint groups). In rats with a partially 
suppressed LH surge, ovulation occurred or the ovaries contained unaffected 
graafian follicles on the day following the stress. In restraint rats with a completely 
blocked LH surge (< detectable levels), LH and FSH levels were not elevated the 
next day, indicating that the surge of gonadotropins had not been delayed by one 
day. The ovaries of these rats indeed contained unaffected graafian follicles. The 
results of this study indicate that, during pro-oestrus, restraint stress suppresses 
(and does not delay) the release of preovulatory gonadotropins in the intact female 
rat. Partial suppression of the LH surge by restraint induces ovulation or ovulation 
had not occurred and the graafian follicles were unaffected. 
The following chapters are focused on the central mechanisms involved in the 
inhibition of the pro-oestrous surge of gonadotropins by restraint stress. An 
interaction of hormones and neuropeptides of the HPA axis (e.g. CRH, AVP and 
ßEND) with those of the HPG axis (e.g. GnRH, LH and FSH) has been suggested. 
It has been reported that central administration of CRH (the major neuromodulator 
of the HPA axis) to male or ovariectomized female rats results in a suppression of 
LH-, but not of FSH-release (9-14). In addition, prolonged administration of CRH 
can cause downregulation of CRH receptors (1 5-17) which may alter its effect on 
the LH and FSH surge. Therefore, Chapter 3 deals with the effects of central 
administration of CRH on the pre-ovulatory surge of LH and FSH in the intact 
female rat. An icv injection (bolus) or infusion (6-h) with CRH resulted in an 
inhibition of the LH surge and to a lesser degree, the FSH surge. The inhibition of 
pro-oestrous LH surge levels lasted 3-4 h; subsequently LH increased to control 
surge levels. A 9-h infusion of CRH which was started 4 h before the presumed 
onset of the surge, however, did not affect the surge of LH and FSH. This indicates 
that CRH can inhibit the LH surge (and to a lesser extent the FSH rise) for only 3-4 
h and that thereafter adaptive mechanisms are activated that restore LH secretion 
to surge levels even in the presence of CRH. Inhibition of LH by CRH can occur via 
activation of the endogenous opioid ßEND (11,18-20), and AVP may mediate the 
CRH-induced ßEND release (21). Therefore, we investigated if the inhibitory effect 
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of CRH on the LH and FSH surge was modified by icv pretreatment with an AVP-
antiserum. Pretreatment (icv) with AVP-antiserum did not prevent but, on the 
contrary, prolonged the inhibitory effect of CRH on the pro-oestrous LH surge. 
Pretreatment with AVP-antiserum before the start of the 9-h CRH infusion resulted 
in a suppression of the LH surge. AVP-antiserum alone did not influence pro-
oestrous LH surge levels. These results indicate that AVP-antiserum pretreatment 
potentiates the inhibitory effect of CRH on the pro-oestrous LH surge. Therefore, 
we suggest that during high central levels of CRH, - as are obtained after icv 
injection and may occur during stress - AVP pathways become activated that 
mitigate the suppression of LH release. 
In Chapter 4 experiments are described in which we investigated the role of 
endogenous CRH and AVP in the inhibitory effect of restraint stress on the pro-
oestrous LH surge. Many behavioural and physiological effects observed during 
stress can be mimicked by central administration of CRH (22), and CRH release is 
observed during stress (23-25). Additionally, in chapter 3 we showed that central 
administration of CRH can inhibit the LH surge in the intact cyclic female rat. A 
possible involvement of endogenous CRH in the restraint-induced inhibition of the 
LH surge was investigated by icv administration of the CRH antagonist a-helical 
CRH before application of restraint stress. In pro-oestrous rats, pretreatment with 
a-helical CRH did not affect the induced suppression, whereas the restraint-induced 
corticosterone response was partially prevented by both doses of the antagonist. 
These data suggest that CRH pathways activated during restraint stress do not 
mediate the inhibitory effect on LH surge levels. As suggested before, high central 
CRH levels may activate AVP pathways and several studies suggest some role of 
AVP in the control of LH secretion during stress. Therefore, we pretreated pro-
oestrous rats with AVP-antiserum and then subjected them to restraint stress. In 
control rats, restraint stress partially inhibited the LH surge. Pretreatment (icv) with 
AVP-antiserum potentiated this inhibition. This result indicates that the residual 
surge seen in control rats is the result of a stimulatory AVP neuronal pathway 
activated by restraint stress. In an additional experiment, iv treatment with the 
GnRH agonist Ovalyse" during restraint resulted in a steep and transient rise of LH 
levels, indicating that the pituitary was not rendered refractory to GnRH. 
During the oestrous cycle opioids tonically inhibit secretion of gonadotropins 
through inhibition of GnRH release, except for the period during the preovulatory 
surge of gonadotropins (26-28). Morphine or ßEND administration before the onset 
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of the LH surge can inhibit the spontaneous or steroid-induced LH surge (29-33). 
Blockade of opioids receptors with the antagonist naloxone before the presumed 
onset of the LH surge, induces a premature surge (33,34). Several studies have 
suggested a role for opioids in the effects of stress on reproductive functions 
(inducing the inhibitory effects on LH secretion) but only a few have used intact 
female rats (1,2). In Chapter 5 experiments are described which investigate the role 
of opioids in the restraint-induced inhibition of the LH surge in the intact cyclic 
female rat. The aim of our experiments was to distinguish between the putative 
role of opioids in mediating the inhibitory effect of restraint on the LH surge and 
their role in the cyclic regulation of LH secretion. Repeated iv injections with the 
opioid antagonist naloxone during restraint did not affect the restraint-induced 
suppression of the pro-oestrous LH surge, neither did pretreatment with naloxone 
or naltrexone, a longer acting opioid antagonist. This indicates that opioids are not 
critically involved as mediators in the restraint-induced suppression of the LH surge 
in the intact female rat. Pretreatment with naltrexone did induce a premature rise 
of LH levels, indicating, in line with results from others, that there is an inhibitory 
tone of endogenous opioids at that time, and that withdrawal of this inhibition can 
lead to initiation of an LH surge (34-37). 
GABA is a major inhibitory neurotransmitter in the brain, and under non-stress 
conditions it is involved in the regulation of GnRH release. For instance, it appears 
to play a role in the negative feedback action of oestrogen on the GnRH release 
(38-43). Additionally, there is evidence that stress can alter GABAergic activity in 
the brain (44). Yet, a relationship between the stress effects on reproductive 
functions and GABAergic activity has not been established. In Chapter 6 we 
investigated the role of GABA in the restraint-induced inhibition of the preovulatory 
LH surge. First, we determined the effect central GABA mechanisms on the pro-
oestrous LH secretion. Indeed, icv administration of the GABAA receptor agonist 
muscimol as well as the GABAB receptor agonist baclofen inhibited the LH surge. 
These data accord with studies obtained by others in ovariectomized and 
ovariectomized/steroid-primed female rats (45-49). To investigate the conceivable 
involvement of GABA in the inhibitory effect of restraint on the LH surge, pro-
oestrous rats were given an icv injection with the GABAA receptor antagonist 
bicuculline, or with the GABAB receptor antagonist phaclofen, and were 
subsequently subjected to restraint stress. Neither of these pretreatments, 
however, prevented the restraint-induced suppression of the LH surge. These data 
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suggest that activation of GABA receptors does likely not mediate the inhibitory 
effect of restraint on the LH surge of the intact female rat. 
In summary, the experiments performed with intact cyclic female rats described 
in this thesis yielded the following conclusions; 
- restraint stress during pro-oestrus can lead to (partial or complete) suppression 
of the release of preovulatory gonadotropins. Even when the surge is largely 
suppressed, the residual LH surge is sufficient to induce ovulation; in case of 
complete suppression, the graafian follicles remain unaffected and ovulation does 
not occur. 
- exogenous CRH can inhibit the pro-oestrous LH surge (and to a lesser extent the 
FSH surge), but this effect is only temporary even when prolonged icv infusions 
with high doses are given ("escape" after 3-4 h). Pretreatment with AVP-
antiserum prolongs the inhibitory effect of CRH on LH. 
- exogenous CRH can activate a vasopressinergic mechanism that counteracts the 
inhibitory effects of CRH on the surge, and underlies the "escape". 
- during restraint stress CRH pathways are activated that result in a corticosterone 
response, but appear not to be critically involved in the restraint-induced 
inhibition of the pro-oestrous LH surge. 
- during restraint stress, a vasopressinergic mechanism is activated in the brain, 
that apparently stimulates LH secretion and can sustain an LH surge. 
- endogenous opioids do likely not mediate the effect of restraint. Yet, an 
inhibitory opioid tone exists (also under non-stress conditions) in the period 
preceding the LH surge. Withdrawal of this tone can yield a premature surge. 
- pharmacological stimulation of GABA receptors in the brain can inhibit the LH 
surge in the intact cyclic female rat via GABAA and GABAB receptors. GABA 
receptors, however, appear not to be involved in the inhibitory effect of restraint 
stress on the pro-oestrous LH surge of the intact female rat. 
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Glossary 
a-MSH 
ßEND 
ACTH 
AHA 
ARC 
AVP 
CNS 
CRF 
CRH 
DBB 
EOP 
FSH 
GABA 
GABA-T 
GAD 
GnRH 
HPA 
HPG 
icv 
LH 
LUF 
ME 
MPN 
MPOA 
OVX 
OXT 
POMC 
PVN 
SCN 
SON 
a-melanocyte stimulating hormone 
ß-endorphin 
adrenocorticotropic hormone 
anterior hypothalamic area 
arcuate nucleus 
arginine vasopressin 
central nervous system 
corticotropin releasing factor 
corticotropin releasing hormone 
diagonal band of Broca 
endogenous opioid peptides 
follicle stimulating hormone 
gamma aminobutyric acid 
GABA-a-oxoglutarate transaminase 
L-glutamic acid decarboxylase 
gonadotropin releasing hormone 
hypothalamus-pituitary-adrenal 
hypothalamic-pituitary-gonadal 
intracerebroventricular 
luteinizing hormone 
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Inleiding 
Het doel van het in dit proefschrift beschreven onderzoek was een beter inzicht te 
krijgen in het effect van stress op de hypothalamus-hypofyse-gonaden as in de 
intacte cyclische rat. 
Hoofdstuk 1 geeft een korte beschrijving van stress en de regulatie van de 
oestrische cyclus in de rat. Het geeft ook een kort overzicht van mechanismen die 
mogelijk betrokken zijn bij de door stress geïnduceerde remming van voort-
plantingsfuncties. De hoofdstukken 2 t/m 6 bechrijven de studies naar het effect 
van stress op de hypothalamus-hypofyse-gonaden as in de intacte cyclische rat. 
Stress 
Ondanks een steeds weer veranderend extern milieu kan een individu zijn interne 
milieu binnen bepaalde grenzen handhaven (homeostase). Indien de homeostase 
wordt bedreigd of verstoord, reageert het individu met een gedrags- en 
fysiologische verdedigingsrespons, de stressrespons. Deze heeft tot doel de 
bedreiging/verstoring weg te nemen en het biologisch evenwicht te herstellen. 
Of een stimulus de homeostase bedreigt of verstoort, en, zo ja, hoe moet worden 
gereageerd, wordt in de hersenen beoordeeld. Het resultaat van dat beoordelings-
proces hangt niet alleen af van de eigenschappen van de stimulus (bv intensiteit, 
duur, frequentie). Ook karakteristieken van het individu, zoals genetisch of tijdens 
de ontwikkeling vastgelegde eigenschappen, opgedane ervaringen en vaardigheden, 
en de actuele psycho-fysiologische staat van het individu, spelen daarbij een 
belangrijke rol. Ook de organisatie, coördinatie en evaluatie van de gedrags-
fysiologische stressrespons gebeurt door de hersenen. 
De gedragsrespons tijdens stress vormt meestal de feitelijke verdediging tegen de 
stressprikkel en is gericht op beëindiging van de stresssituatie (adaptatie). De 
fysiologische veranderingen, teweeggebracht via het autonome zenuwstelsel en het 
hormonale systeem, maken die gedragsrespons mogelijk door mobilisatie en 
redistributie van energie. Een snelle autonome activatie zorgt voor een onmid-
dellijke, verhoogde beschikbaarheid van energie. Relatief trage, hormonale 
mechanismen zijn met name van belang voor het beschikbaar maken van energie 
op de langere termijn. Daarbij speelt activering van de hypothalamus-hypofyse-
bijnier as (HHB-as) een centrale rol. 
De fysiologische stressrespons kan worden gezien als een herijking van de 
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prioriteiten in het individu. Fysiologische processen die energie verbruiken (anabole 
processen) alsmede onder stressomstandigheden een lage prioriteit hebben, zoals 
groei, immuniteit, herstel, vertering maar ook reproduktieve activiteit (het 
onderwerp van dit proefschrift), worden (tijdelijk) geremd. Dit gebeurt ten gunste 
van processen die een verdedigingsrespons mogelijk moeten maken. De stress-
respons heeft dus een prijs die meestal gering is, maar die tijdens langdurige stress 
kan leiden tot stoornissen en ziekten. 
Regulatie van de oestrische cyclus in de rat 
De oestrische cyclus van de rat duurt 4 of 5 dagen en bestaat uit verschillende 
stadia; pro-oestrus, oestrus, metoestrus en dioestrus. Deze stadia zijn goed te 
volgen omdat onder invloed van geslachtshormonen het epitheel van de 
vaginawand een cyclus doormaakt. Door het maken van vaginale uitstrijkjes kan 
men bepalen in welk stadium van de cyclus de rat zich bevindt. De cyclus wordt 
gereguleerd door hormonen. Het systeem waarbinnen de interactie tussen de 
verschillende voortplantingshormonen zich afspeelt, wordt aangeduid als de hypo-
thalamus-hypofyse-gonaden as (HHG-as). Het ovarium wordt door de hypofyse-
hormonen LH (luteïniserend hormoon) en FSH (follikel stimulerend hormoon) 
aangezet tot produktie en afgifte van oestrogenen en progesteron. De afgifte van 
LH en FSH wordt gereguleerd door het GnRH (gonadotropin-releasing hormone) 
afkomstig uit de hypothalamus. 
Tijdens oestrus, metoestrus en dioestrus zorgen de geslachtshormonen via 
negatieve terugkoppeling voor een remming van de afgifte van zowel GnRH als LH 
en FSH. Tijdens pro-oestrus leidt een verhoogde concentratie van oestrogenen via 
positieve terugkoppeling tot een kortstondige verhoogde afgifte van GnRH en 
vervolgens dus van LH (de LH-piek) en FSH (de FSH-piek). Het verloop van de 
cyclus wordt beïnvloed door de afwisseling van de licht- en donkerperioden. Het 
mechanisme dat het tijdstip van de preovulatoire LH- en FSH-piek regelt vertoont 
een 24-uurs ritme. Het begin van de LH- en FSH-piek valt ongeveer 2 uur na het 
midden van de lichtperiode waarbij de ratten gehuisvest zijn. De LH-piek induceert 
hervatting van de méiose van de eicel, ovulatie en luteïnisatie. De FSH-piek zorgt 
voor de ontwikkeling van een nieuwe set van follikels tot graafse follikels. Tijdens 
pro-oestrus wordt er naast een verhoging van de oestrogeenproduktie ook meer 
progesteron geproduceerd, dat vervolgens de afgifte van LH en FSH weer remt 
(negatieve terugkoppeling). 
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Stress en voortplanting 
Stress kan leiden tot een verstoring van voortplantingsfuncties. Er is daarover al 
veel onderzoek gedaan. In het algemeen wordt gedacht dat vrouwelijke dieren 
gevoeliger zijn voor stress dan mannelijke dieren. De ovariële cyclus is immers 
afhankelijk van een ingewikkeld samenspel van tijdsgebonden neuro-endocrien 
gereguleerde veranderingen, en verstoring van één enkel proces daarin kan leiden 
tot verminderde vruchtbaarheid. Met name de mechanismen die het bronstgedrag, 
en de LH- en FSH-piek reguleren, zijn gevoelig voor stress. De experimentele 
evidentie daarvoor is echter vooral afkomstig uit onderzoek uitgevoerd met intacte 
en gecastreerde mannelijke ratten en met vrouwelijke, geovariëctomeerde ratten, 
die al dan niet met oestrogenen behandeld zijn. In deze diermodellen is met name 
het effect van stress op de basale LH-afgifte bestudeerd. De hormonale status van 
deze dieren verschilt echter duidelijk van die van intacte cyclische vrouwelijke 
ratten. Het is daarom goed mogelijk dat intacte vrouwtjes geheel anders op stress 
reageren dan geovariëctomeerde. Bij de intacte cyclische rat is er echter nog maar 
weinig onderzoek gedaan naar de invloed van stress op voortplantingsfuncties. 
Onderzoek naar de invloed van stress op voortplantingsfuncties bij het intacte 
vrouwelijke dier, en de daarbij betrokken mechanismen wordt bemoeilijkt door de 
complexiteit van de regulatie van de ovariële cyclus. Bovendien veranderen door 
stress een groot aantal (neurale en hormonale) mechanismen in de hersenen en 
periferie in activiteit. In de literatuur wordt een verband gesuggereerd tussen de 
hormonen van de HHB-as die tijdens stress geactiveerd worden en de hormonen 
van de HHG-as. Centrale toediening van corticotropin-releasing hormone (CRH), 
Vasopressine (AVP) of ß-endorphin (ßEND) leidt inderdaad tot een remming van de 
LH-afgifte en blokkering van de ovulatie. Omdat die neuropeptiden/ hormonen een 
belangrijke rol spelen bij tal van stressresponsen, wordt gedacht dat het effect van 
stress op de HHG-as ook bij het intacte vrouwelijke dier via deze 
neuropeptiden/hormonen tot stand komt. Ook tal van andere factoren die tijdens 
stress vrijkomen kunnen echter betrokken zijn bij de door stress geïnduceerde 
onderdrukking van voortplantingsfuncties, waaronder bijvoorbeeld gamma amino-
butyric acid (GABA), de belangrijkste inhiberende neurotransmitter in de hersenen. 
Overzicht van de in dit proefschrift beschreven studies 
Hoofdstuk 2 beschrijft het onderzoek waarin het effect bestudeerd wordt van 
verschillende perioden van restraint-stress op de preovulatoire LH- en FSH-piek en 
de ovulatie in de intacte cyclische rat. In deze studies verstaan we onder restraint-
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stress het opgesloten zitten in een perspex cilinder waardoor de rat in haar 
bewegingsvrijheid wordt beperkt. In het geringe aantal beschreven studies met 
intacte vrouwelijke ratten is aangetoond 1) dat de LH-piek en ovulatie onderdrukt 
worden door voetschok-stress, en dat ovulaties ook geremd kunnen worden door 
immobilisatie-stress; 2) dat de LH-piek 24 uur uitgesteld kan worden indien tijdens 
pro-oestrus de piek geblokkeerd is waardoor alsnog - zij het 24 uur later - ovulatie 
kan optreden; 3) dat een gedeeltelijk onderdrukte LH-piek veranderingen in het 
ovulatieproces kan bewerkstelligen. In ratten die geïnjecteerd zijn met een kleine 
hoeveelheid LH in de ochtend van de pro-oestrus, wordt namelijk de méiose hervat. 
Bovendien wordt dan een vroegtijdige luteïnisatie van de follikels geïnduceerd 
waardoor de eisprong niet meer kan optreden. 
In het onderzoek beschreven in hoofdstuk 2 werden ratten in pro-oestrus 
onderworpen aan restraint-stress vanaf het tijdstip 0, 1 of 2 uur vóór het verwachte 
begin van de LH-piek tot vlak voor de donkerperiode. De restraintperiode bestreek 
daardoor bijna de gehele periode van de LH-piek. Restraint resulteerde in een totale 
of gedeeltelijke onderdrukking van de LH- en FSH-piek (geen significant verschil 
tussen de 3 restraintprotocols). In gestresste ratten waarbij geen LH-piek meer 
detecteerbaar was, waren de LH- en FSH-waarden de volgende dag niet verhoogd. 
In ratten met een gedeeltelijk onderdrukte LH-piek, bleek het effect van stress op 
de ovulatie nogal variabel: bij sommige dieren traden er normaal ovulaties op, bij 
andere was de ovulatie geheel geblokkeerd en bevatte het ovarium de volgende dag 
onveranderde graafse follikels. De resultaten van deze studie tonen aan dat 
restraint-stress kan leiden tot een totale onderdrukking van de LH-piek en daardoor 
tot blokkering van de ovulatie, en dat totale onderdrukking van de LH-piek tijdens 
pro-oestrus niet leidt tot uitstel van de piek (en dus ovulatie) met 24 uur. Bovendien 
geven de resultaten aan dat ook na een sterk gereduceerde LH-piek nog ovulatie 
kan optreden. Het is niet duidelijk of er een relatie bestaat tussen de hoogte van de 
residuele LH-piek en het ovulatieproces. Een licht verhoogde afgifte van LH 
gedurende een bepaalde tijd lijkt voldoende te zijn om ovulatie te kunnen induceren. 
Hoofdstuk 3 t/m 6 gaan over centrale mechanismen waarvan bekend is dat ze 
tijdens stress kunnen worden geactiveerd, en die betrokken zouden kunnen zijn bij 
de door restraint-stress geïnduceerde onderdrukking van de pro-oestrische LH- en 
FSH-piek. De literatuur suggereert een interactie tussen de hormonen en 
neuropeptiden van de HHB-as, zoals CRH, AVP en ßEND, met die van de HHG-as, 
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zoals GnRH, LH en FSH. Maar ook andere factoren, in het bijzonder GABA, zouden 
een rol kunnen spelen. 
Het is bekend dat een centrale (icv) injectie met CRH (de belangrijkste modulator 
van stress-reacties) in mannelijke en geovariëctomeerde vrouwelijke ratten 
resulteert in een onderdrukking van de LH-, maar niet van de FSH-afgifte. 
Langdurige icv toediening van CRH kan leiden tot een vermindering van CRH-
receptoren wat mogelijk een verandering in het effect van CRH op de LH- en FSH-
piek kan veroorzaken. Hoofdstuk 3 beschrijft het onderzoek waarin het effect 
bestudeerd wordt van CRH op de preovulatoire LH- en FSH-piek in de intacte 
cyclische rat. Een icv injectie of een 6-uur durend infuus met CRH (gegeven, 
respectievelijk gestart, 1 uur voor het begin van de LH-piek) resulteerde in een 
onderdrukking van de LH-piek en in mindere mate van de FSH-piek. De 
onderdrukking van LH duurde 3-4 uur, waarna vervolgens het LH-niveau steeg tot 
het niveau van de controle groep op een vergelijkbaar tijdstip van de surge. Een 9-
uur durend infuus met CRH dat 4 uur voor het begin van de LH-piek was gestart, 
had géén onderdrukkend effect op de LH- en FSH-piek. Dit duidt erop dat CRH de 
afgifte van LH (en in mindere mate van FSH) maar tijdelijk (3-4 uur) kan onder-
drukken, mogelijk doordat er mechanismen geactiveerd worden die er na enige tijd 
voor zorgen dat de LH-afgifte tot het niveau van de controle wordt hersteld. 
Volgens literatuurgegevens, zou de onderdrukking van LH door CRH kunnen 
verlopen via stimulering van de ßEND-afgifte; de door CRH geïnduceerde ßEND-
afgifte zou via AVP tot stand komen. We hebben daarom onderzocht of het 
remmende effect van CRH op de LH- en FSH-piek kon worden voorkomen door de 
dieren icv vooraf te behandelen met een AVP-antiserum. Door zo'n voorbehandeling 
wordt AVP gebonden, en kan het zijn werking niet uitoefenen. We vonden echter 
dat voorbehandeling met AVP-antiserum leidde tot een verlenging van het 
onderdrukkende effect van CRH op de LH-afgifte. In AVP-antiserum voorbehandelde 
dieren leidde een 9-uur durend infuus met CRH, gestart 4 uur voor het verwachte 
begin van de LH-piek, tot een vrijwel volledig onderdrukte LH-piek. In niet aan 
stress blootgestelde controle ratten had het AVP-antiserum zelf geen effect op de 
LH-piek. Deze resultaten wijzen erop dat hoge CRH-concentraties in de hersenen 
kunnen leiden tot afgifte van AVP in de hersenen, waardoor de door CRH 
geïnduceerde onderdrukking van de LH-afgifte wordt tegengegaan. 
Veel effecten die tijdens stress worden waargenomen, kunnen worden 
nagebootst door centrale toediening van CRH. In hoofdstuk 3 is reeds aangetoond 
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dat CRH de LH-piek kan onderdrukken in de intacte cyclische rat. Uit de literatuur 
is bekend dat gedurende stress de afgifte van CRH en AVP wordt gestimuleerd. In 
de literatuur wordt een betrokkenheid van beide factoren gesuggereerd in de 
controle van de LH-afgifte gedurende stress. Hoofdstuk 4 beschrijft het onderzoek 
waarin de rol van CRH en AVP onderzocht werd in het onderdrukkende effect van 
restraint-stress op de pro-oestrische LH-piek. Blokkering van de CRH receptoren 
door de CRH receptor-antagonist a-helical CRH vóór het begin van de 
restraintperiode had geen effect. De door stress geïnduceerde corticosteron-respons 
werd wel gedeeltelijk tegengegaan door de CRH-antagonist. Deze resultaten 
suggereren dat gedurende restraint-stress CRH-systemen in de hersenen worden 
geactiveerd, maar dat die niet betrokken zijn bij het remmende effect op de LH-
afgifte. Zoals hierboven is vermeld, zouden hoge CRH-concentraties in de hersenen 
die bv tijdens stress voorkomen, een AVP-systeem kunnen activeren. Aan ratten 
in pro-oestrus is daarom icv AVP-antiserum toegediend voordat ze aan restraint-
stress werden onderworpen. Restraint veroorzaakte een gedeeltelijke onderdrukking 
van de LH-piek. In ratten die voorbehandeld waren met het AVP-antiserum was 
deze onderdrukking aanzienlijk sterker. Dit resultaat toont aan dat het residu van 
de LH-piek dat nog in gestresste controle ratten wordt waargenomen, mogelijk het 
gevolg is van een door restraint geactiveerd stimulatoir AVP-systeem. 
Om uit te sluiten dat door restraint-stress de gevoeligheid van de hypofyse voor 
GnRH veranderd wordt, is aan ratten in pro-oestrus, tijdens restraint, de GnRH 
agonist Ovalyse19 toegediend. Dit resulteerde in een snelle en kortstondige stijging 
van het LH-niveau, hetgeen erop wijst dat restraint niet leidt tot ongevoeligheid van 
de hypofyse voor GnRH. Het is daarom waarschijnlijk, dat het remmende effect van 
restraint op LH plaatsvindt op het niveau van de hypothalamus. 
Endogene opioïden in de hersenen spelen een rol in de regulatie van de oestrische 
cyclus. Ze vormen een schakel in de negatieve terugkoppeling van de oestrogenen 
op de GnRH-afgifte. Blokkering van opiaatreceptoren door de opiaatreceptor-
antagonist naloxone voor het begin van de LH-piek kan dan ook leiden tot een 
voortijdige start van de LH-piek. Meerdere studies suggereren een rol voor 
endogene opioïden in het remmende effect van stress op voortplantingsfuncties. 
Echter maar in één enkel onderzoek werd gebruik gemaakt van intacte vrouwelijke 
ratten. In dit onderzoek kon het onderdrukkende effect van voetschok-stress 
gedeeltelijk worden voorkomen door de dieren vooraf te behandelen met naloxone. 
In hoeverre hier sprake was van een vervroeging van de LH-piek, of van een 
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werkelijk antagonisme van door stress geactiveerde endogene opioidsystemen, is 
onduidelijk. Hoofdstuk 5 beschrijft het onderzoek waarin de rol van endogene 
Opioiden bestudeerd wordt in de door restraint-stress geïnduceerde onderdrukking 
van de LH-piek in de intacte cyclische rat. Het doel was onderscheid te maken 
tussen de rol van endogene Opioiden tijdens de cyclische regulatie van de LH-afgifte 
en de vermeende rol van endogene opioïden tijdens het onderdrukkende effect van 
restraint-stress op de LH-piek. Herhaalde intraveneuze injecties met naloxone tijdens 
de restraintperiode hadden geen effect op de door stress geïnduceerde 
onderdrukking van de LH-piek. Ook een injectie met naloxone of met de langer 
werkende antagonist naltrexone voorafgaande aan de restraintperiode had geen 
effect. De voorbehandeling met naltrexone resulteerde echter wel in een voortijdige 
stijging van het LH-niveau. Uit de resultaten kan worden afgeleid dat endogene 
opioïden geen rol spelen in de door restraint geïnduceerde onderdrukking van de LH-
piek in de intacte cyclische rat. In overeenstemming met de resultaten van 
onderzoek door anderen is gevonden dat het onderbreken van de remming door 
opioïden tijdens de periode voorafgaande aan de LH-piek in de intacte rat kan leiden 
tot een voortijdige LH-piek. 
GABA is een belangrijke, inhiberende, neurotransmitter in de hersenen en is 
betrokken bij de regulatie van GnRH-afgifte. Het lijkt een rol te spelen in de 
negatieve terugkoppeling van oestrogenen op de GnRH-afgifte. Uit literatuur-gege-
vens blijkt dat stress de GABAerge activiteit in de hersenen kan beïnvloeden. Tot 
nu toe is echter een verband tussen het effect van stress op voortplantingsfuncties 
en een veranderde GABAerge activiteit niet vastgesteld. Hoofdstuk 6 beschrijft het 
onderzoek naar de betrokkenheid van GABA bij de door restraint-stress geïn-
duceerde onderdrukking van de LH-piek in de intacte cyclische rat. In eerste 
instantie is het effect van centrale activatie van GABA mechanismen op de pro-
oestrische LH-afgifte bestudeerd. Zowel de icv geïnjecteerde GABAA receptor-
agonist muscimol als de GABAB receptor-agonist baclofen waren in staat de LH-piek 
te onderdrukken. Dit komt overeen met het resultaat van studies waarin gebruik is 
gemaakt van geovariëctomeerde en geovariëctomeerde/oestrogeen behandelde 
vrouwelijke ratten. Om een mogelijke rol van GABA vast te stellen in het 
onderdrukkende effect van restraint op de LH-piek, zijn ratten in pro-oestrus icv 
geïnjecteerd met de GABAA receptor-antagonist bicuculline of met de GABAB 
receptor-antagonist phaclofen alvorens ze werden onderworpen aan restraint-stress. 
Geen van beide antagonisten hadden invloed op de door restraint geïnduceerde 
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remming van de LH-piek. Dit resultaat suggereert dat het onderdrukkende effect 
van restraint-stress op de LH-piek bij de intacte cyclische rat niet tot stand komt 
via GABA receptoren. 
Conclusie 
De resultaten beschreven in dit proefschrift tonen aan dat restraint-stress tijdens 
pro-oestrus leidt tot een onderdrukking van de preovulatoire LH- en FSH-piek. Een 
totaal onderdrukte LH-piek gaat gepaard met een totale blokkering van de ovulatie. 
Een sterk gereduceerde LH-piek is nog in staat om ovulatie te induceren. CRH, 
Opioiden en GABA lijken niet betrokken te zijn bij de door restraint geïnduceerde 
onderdrukking van de LH-piek in de intacte cyclische rat. Door centrale toediening 
van CRH, en ook tijdens stress, wordt in ratten in pro-oestrus een AVP-systeem 
geactiveerd dat een totale onderdrukking van de LH-piek voorkomt. De intacte 
vrouwelijke rat is daardoor in staat het effect van stress op de HHG-as tijdens pro-
oestrus te beperken, zodat het reproduktief vermogen gehandhaafd blijft. 
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